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Group A Streptococcus (GAS) is a major bacterial causative agent of a wide variety of 
human diseases that range from mild superficial infections such as impetigo, and 
pharyngitis, to more serious invasive infections, and numerous autoimmune sequelae. 
Globally, GAS is estimated to cause 700 million infections, and accounts for half a million 
deaths per year, and consequently poses a considerable burden financially and on 
healthcare systems. Of the GAS disease etiologies, GAS pharyngitis is the most common 
disease manifestation, with an annual estimate of 616 million cases globally. Penicillin is 
the standard antibiotic treatment of GAS infections. Whilst GAS remains sensitive to 
penicillin, an alarming antibiotic treatment failure rate of 20-40% has been reported. It has 
been proposed that GAS may exist as biofilms in the pharynx contributing to persistent and 
recurrent pharyngitis that is non-responsive to antibiotic treatment. In vitro, plate-based 
models have shown that several GAS M-types form biofilms, and multiple GAS virulence 
factors have been linked to biofilm formation. Although the contributions of these plate-
based studies have been valuable, most have failed to mimic the host environment, with 
many studies utilising abiotic surfaces. Moreover, GAS is a human specific pathogen, and 
colonisation and subsequent biofilm formation is likely facilitated by distinct interactions 
with host tissue surfaces. Thus, the overarching aim of chapter 2 was to optimise a GAS 
biofilm-host pharyngeal cell model to support and grow GAS biofilms of a variety of GAS 
M-types. Improvements and adjustments to the crystal violet biofilm biomass assay were 
also tailored to reproducibly detect delicate GAS biofilms. 72 h was deemed as an optimal 
growth period for yielding detectable biofilm biomass. The GAS biofilms formed were 
robust and durable, and can be reproducibly assessed via staining/washing intensive assays 
such as crystal violet with the aid of methanol fixation prior to staining. SEM imaging of 
GAS biofilms formed by this model resembled those previously found on excised tonsils 
of patients suffering chronic pharyngo-tonsillitis. Taken together, an efficacious GAS 
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biofilm host-cell model has been developed that can support long-term GAS biofilm 
formation, with biofilms formed closely resembling those seen in vivo.  
The host cell surface is integral in early host-pathogen interactions, thus there is a need to 
better understand the role of host cell surface receptors in GAS biofilm formation. Whilst 
this process is complex, dynamic, and multifaceted, glycans which are abundantly present 
on all host epithelial surfaces have recently gained attention as an important component 
mediating GAS pathogenesis. However, much remains to be understood of the glyco-
interactions occurring at the host-GAS interface, with much of the prior research having 
only been conducted in the context of planktonic GAS. Utilising the previously optimised 
GAS-pharyngeal cell biofilm model, chapters 3 and 4 describe, for the first time, the 
biofilm forming abilities of a variety of GAS M-types on modified pharyngeal monolayers. 
The targeted removal of terminal mannose and sialic acid, which predominate the surface 
of Detroit 562 pharyngeal cells, increased biofilm biomass with EPS production implicated 
for some M-types. These increases in biofilm biomass occurred in a glycan- and strain-
dependent manner, suggesting that the influence of the host glycome on the biofilm 
phenotype is not limited to a single strain or M-type. M12 GAS biofilms formed on pre-
modulated glycomic pharyngeal cell surface monolayers were further interrogated for their 
penicillin susceptibility, with findings indicating significantly increased penicillin 
tolerance for biofilms grown on pharyngeal cell surfaces that were exoglycosidase pre-
treated. Taken together, this study describes the effect of host glycosylation on GAS 
biofilm formation, and GAS biofilm formation as an important proponent in penicillin 
tolerance. Given the increasingly appreciated importance of glycans in the host-pathogen 
relationship and the abundance of glycosylated structures in the oropharynx, this work 
contributes to an improved understanding of the role of host glycans in the pathogenesis of 
GAS pharyngitis and antibiotic treatment failure, and may contribute towards the 
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Chapter 1: Introduction 
A part of this work has been published in Current Drug Targets, Bentham Science.   
Overview: Streptococcus pyogenes (Group A Streptococcus; Group A streptococci; GAS) 
is a Gram-positive pathogen, known to cause an array of diseases ranging from mild, 
superficial infections such as impetigo, and pharyngitis, to more serious invasive 
infections, and numerous autoimmune sequelae. Despite GAS remaining sensitive to 
penicillin, antibiotic treatment failure rates of 20-40% have been reported. It has been 
proposed that GAS may exist as biofilms. Biofilms are microbial communities that can 
aggregate upon a surface and exist within a self-produced matrix of extracellular polymeric 
substances. Biofilms offer bacteria an increased survival advantage, in which bacteria 
persist and tolerate host immunity and antimicrobial treatment. The biofilm phenotype has 
long been recognised as a virulence mechanism for many Gram-positive and Gram-
negative bacteria, however, very little is known about the role of GAS biofilms in 
pathogenesis.  
Several virulence factors have been implicated in GAS biofilm formation. However, most 
models use abiotic surfaces for biofilm growth and poorly represent the in vivo 
environment of the host. The host cell surface is integral in initial host-pathogen 
interactions, bacterial cell adherence, and subsequent biofilm formation. Thus, there is a 
need to better understand the role of host cell surface receptors in GAS biofilm formation. 
Glycans decorate most epithelial cell surfaces and are the initial point of contact for many 
pathogens, including GAS. There is a growing body of evidence that implicates glycans in 
planktonic GAS adherence, however, their role in GAS biofilm formation has not been 
previously investigated. Herein, GAS biofilm formation has been thoroughly reviewed in 
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the context of virulence factors, biofilm models, and the role of human pharyngeal glycans 
in bacterial adherence and biofilm formation.  
1.1.  Biofilms in GAS pathogenesis 
Biofilm formation is recognised as a virulence mechanism for a variety of Gram-positive 
and Gram-negative bacterial species (Zalewska-Piatek et al., 2009, Abee et al., 2011, Al-
Wrafy et al., 2017). The presence of GAS biofilms in a variety of clinical infections 
suggests this phenotype may play a role in GAS pathogenesis (Roberts et al., 2012, 
Siemens et al., 2016). While multiple studies have characterised the role of various GAS 
virulence factors in biofilm formation, studies assessing the role of biofilm formation in 
GAS pathogenesis have been limited. To understand GAS as a biofilm it is important to 
understand the biofilm phenotype.  
1.1.1. Bacterial biofilms 
Bacteria can exist either in planktonic or biofilm states. Planktonic cells are singular ‘free 
floating’ entities existing in a liquid environment (Percival et al., 2012), whereas biofilm 
bacteria exist as sessile aggregates encased in a self-produced matrix of extracellular 
polymeric substances (EPS) and may attach to a biological or non-biological surface 
(Bjarnsholt et al., 2008). Biofilm cells vary drastically in their physiology, growth rate, and 
gene expression when compared to planktonic cells. Furthermore, it has become clear that 
bacteria frequently transition between planktonic and biofilm states, which is central to 
biofilm formation and development (Rollet et al., 2009, McDougald et al., 2012).  
1.1.2. Biofilm formation and development 
Biofilm formation is a dynamic, multifaceted process triggered by environmental cues that 
prompt changes in gene expression. This results in a re-organisation of the spatial and 
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temporal arrangement of bacterial cells leading to a transition from the planktonic 
phenotype, to a biofilm (Kostakioti et al., 2013). Overall, biofilm formation and 
development has been well-defined, and can be simplified into 4 steps: i) reversible 
bacterial attachment, ii) irreversible bacterial attachment, iii) biofilm maturation, and iv) 
biofilm dispersal (Kostakioti et al., 2013). In brief, initial reversible attachment of free 
floating planktonic cells to a host tissue surface is a random process, driven by 
environmental cues (e.g. pH, temperature, ions, nutrients and gas/O2 availability), forces 
of gravity, Brownian motion, and local environmental hydrodynamics (Donlan, 2002, 
Shunmugaperumal, 2010). Some motile bacteria may use appendages (e.g. pili and 
flagella) for migration (O'Toole and Kolter, 1998, Caiazza et al., 2007). Upon irreversible 
attachment, EPS, consisting of polysaccharides, proteins, nucleic acids, and lipids is 
produced and this meshwork provides the scaffold for complex, three-dimensional biofilm 
architecture (Abee et al., 2011, Gloag et al., 2013). At this stage, initial micro-colonies 
begin to form (Rutherford and Bassler, 2012). Biofilm maturation is induced by quorum 
sensing signals, which prompt phenotypic changes and genetic diversification. This 
process results in enhanced structural defense against biological, physical, and chemical 
stress, assisting nutrient acquisition by forming complex water/nutrient channels, and 
facilitating enhanced reproductive ability (Wolcott et al., 2008). Dispersal of bacterial cells 
into the host environment is the final stage of the biofilm cycle which can occur passively 
through physical forces such as fluid shear or abrasion, or be induced in response to various 
environmental conditions (e.g. pH, nutrient levels, gas concentrations), highly regulated 
signal transduction pathways, and effectors. Dispersal is key for biofilm re-colonisation 




1.1.3. Biofilm tolerance to immune clearance and antimicrobial agents 
It has been suggested that 99% of the world’s bacteria exist in a biofilm state, highlighting 
an adaptive advantage of this phenotype (Vickery et al., 2013). Biofilms are highly tolerant 
to both antimicrobial treatment and immune action (Davies, 2003). Biofilm communities 
are ~10-1000 fold more tolerant to antimicrobials when compared to their planktonic 
bacterial cell counterparts (Nickel et al., 1985, Prosser et al., 1987). Tolerance displayed 
by biofilm communities is attributed to, but not limited to; i) changes in gene expression, 
ii) sharing of resistance genes via horizontal gene transfer or adaptive mutations, iii) active 
release of antibiotic degrading enzymes, iv) three-dimensional structure, v) the physical 
EPS barrier (to both antibiotics/antimicrobials and immune cells), and vi) reduced 
metabolic activity among some bacterial cells found deep within the biofilm (Brown et al., 
1995, Cowan, 2010, de la Fuente-Núñez et al., 2013).  
1.2.  Evidence of GAS biofilm formation  
GAS is a Gram-positive human bacterium causing several diseases ranging from mild, 
superficial infections such as impetigo, and pharyngitis, to more serious invasive infections 
(necrotising fasciitis, cellulitis, toxic shock syndrome etc), and numerous autoimmune 
sequelae (rheumatic heart disease, rheumatic fever, glomerulonephritis etc) (Walker et al., 
2014). GAS impetigo and pharyngitis are the most common disease manifestations 
contributing significantly to the global incidence and disease burden, estimated at 111 
million and 600 million cases per year respectively (Carapetis et al., 2005, Walker et al., 
2014). 
GAS typically infects the skin and mucosal surface of the oropharynx. The earliest 
evidence for the presence of GAS biofilms in vivo was found in impetigo lesions, where 
glycocalyx encapsulated micro-colonies, resembling early stage biofilm formation, were 
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detected via FITC-ConA staining and visualised under confocal laser scanning microscopy 
(CLSM) (Akiyama et al., 2003). A more recent clinical case study investigated a previously 
healthy male presenting with a necrotising soft tissue infection (NSTI) persisting over 24 
days. The surgeon noted a presence of “thick layer biofilm” in the patient’s fascia (Siemens 
et al., 2016). This observation prompted the team to further investigate biofilm as a 
constituent of GAS NSTI. A multicenter study revealed that 32% of patient tissue biopsies 
(N=31) contained GAS biofilm. The biofilms found in these NSTIs exacerbated 
inflammation and led to severe tissue damage at the site of the NSTI infection, moreover, 
presence of bacterial loads far exceeded those of wound biopsies lacking the biofilm. Taken 
together, these studies highlight the need for further consideration of GAS biofilms as a 
complicating factor in NSTIs.  
GAS enters the throat via the oral cavity and typically colonises the oro-nasopharynx. 
Asymptomatic and persistent oropharyngeal GAS carriage has been in part attributed to 
biofilm formation, complicating and contributing to oropharyngeal disease (Fiedler et al., 
2013). Although penicillin resistant GAS has not been reported, it has been hypothesised 
that GAS biofilms may broadly be a contributing factor to the antibiotic treatment failure 
rate of 20-40% (Lembke et al., 2006, Pichichero and Casey, 2007). A number of clinically 
relevant GAS serotypes (M2, M6, M14, and M18) have been found to form biofilms in 
vitro on both uncoated surfaces, and surfaces coated with human fibronectin, human 
fibrinogen, human collagen types I and IV, and human laminin (Lembke et al., 2006). In a 
study observing GAS pharyngitis and antibiotic treatment failure, all 99 GAS isolates 
collected from patients suffering GAS pharyngitis displayed biofilm forming abilities with 
varying capacities (Conley et al., 2003). The minimum biofilm eradication concentrations 
(MBECs) were overall higher than the minimum inhibitory concentration (MIC) values for 
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all GAS isolates, with penicillin tolerance demonstrated by 60% of the GAS isolates when 
in the biofilm phenotype. This study conducted by Conley et al. (2003) is one of the earliest 
to demonstrate a link between in vitro GAS biofilm formation and penicillin insensitivity, 
highlighting the protective advantages offered by the biofilm phenotype against antibiotics 
like penicillin (Conley et al., 2003).   
Another study investigated 289 differing clinical GAS isolates from carriers, pharyngitis 
cases, and invasive/non-invasive infections in an attempt to understand the link between 
clinical source, biofilm forming ability, and antibiotic insensitivity (Baldassarri et al., 
2006). Although 90% of isolates were found to be biofilm forming in vitro, some emm 
types displayed a greater propensity towards biofilm formation than others, this was 
especially apparent among emm 6 strains when assessed for biofilm biomass. However, 
intra-strain variability within an M-type suggested biofilm formation was strain specific 
rather than an overall characteristic offered by the serotype. Moreover, this study found 
that GAS strains that are less capable of host cell internalisation may utilise the biofilm 
phenotype to survive β-lactam treatment (Baldassarri et al., 2006). A more recent study 
explored biofilm formation by 15 differing GAS emm types frequently isolated from 
patients suffering recurrent GAS pharyngitis (Ogawa et al., 2011). Findings indicated that 
emm types 1, 12, and 28 were most abundant; however the emm6 strains produced 
significantly more biofilm (Ogawa et al., 2011). These GAS biofilms were 10 times more 
tolerant to penicillin, erythromycin, and clindamycin, used individually or in combination, 
when MICs were used for comparison with their planktonic cell counterpart (Ogawa et al., 
2011).  
An in vivo study by Roberts et al. (2012) revealed GAS residing within tonsillar crypts of 
sufferers of recurrent GAS tonsillo-pharyngitis using fluorescence microscopy and 
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scanning electron microscopy. The group also observed cocci chains typical of GAS 
arranged in three-dimensional communities resemblant of biofilms in an ex vivo pig 
epithelium model (Roberts et al., 2012).  
Overall, it is apparent that both the skin and the throat are able to cultivate GAS biofilms 
from the earlier stages of micro-colony formation, to the more mature biofilm communities. 
Moreover, these findings highlight the clinical relevance of GAS biofilms and their 
potential role in antibiotic treatment failure in recurrent GAS infections. Taken together, 
these observations reinforce the need for further investigation into GAS biofilm formation 
in vitro, in vivo, and ex vivo. 
1.2.1. Virulence factors involved in GAS biofilm formation 
GAS expresses multiple virulence factors involved in adherence to host tissue surfaces. 
GAS virulence factor expression is variable among individual strains, and differs among 
GAS serotypes, with expression and regulation impacted by both host and environmental 
stimuli (Walker et al., 2014, Fiedler et al., 2015). Several GAS virulence factors have been 
implicated in various stages of biofilm development (summarised in Table 1.1, and 
schematically depicted in Fig 1.1).  
1.2.1.1. M protein family and lipoteichoic acid 
The M protein is abundantly expressed on the surface of GAS, and numerous studies have 
demonstrated a role for M protein in adherence, as it facilitates attachment of GAS to host 
epithelial cells (Ellen and Gibbons, 1972, Tylewska et al., 1988, Caparon et al., 1991). 
Adherence is both M type and epithelial cell type specific (Smeesters et al., 2010, Walker 
et al., 2014). It has also been proposed that the M protein mediates initial cell-surface 
interactions during biofilm formation. Cho and Caparon (2005) demonstrated this using an 
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isogenic M protein deficient GAS HSC5 (emm14) mutant grown on abiotic polystyrene 
surfaces under static conditions. The mutant displayed a decrease in biofilm biomass 
relative to wild-type through safranin staining. Courtney et al. (2009) also observed 
significantly reduced biofilm biomass, relative to wild-type, for isogenic M protein mutants 
of emm1, 5, 6, and 24 isolates under similar growth conditions. In emm types 1, 5, 6, and 
24, isogenic M protein deficient mutants displayed diminished bacterial hydrophobicity, 
decreased membrane bound LTA, and biofilm biomass relative to wild-type strains. These 
findings demonstrated a correlation between M protein, bound lipoteichoic acid (LTA), 
surface hydrophobicity, and the overall ability to form biofilms. It was suggested that 
complex interactions between M protein and LTA expose the ester fatty acids of LTA, 
increasing bacterial hydrophobicity, ultimately favouring LTA-host cell interactions 
(Courtney et al., 2009). Conversely, no significant reduction in biofilm biomass, 
hydrophobicity and membrane bound LTA was observed for isogenic M protein deficient 
GAS strains for emm2, 4, and 49 expressing strains. Notably, a key difference between the 
strains displaying the M-protein-LTA mediated adherence and those that did not is their 
emm pattern classification. The emm1, 5, 6, and 24 strains all belong to the emm pattern A 
classification, which display a single M protein family member on their surface whilst the 
emm2, 4, and 49 belong to the pattern D and E classification, which express other surface 
proteins of the M protein family, such as the M-related protein (mrp) and M-like protein 
(enn) on their surface (Courtney et al., 2009). Therefore, it appears that the M-protein and 
LTA interaction is specific to strains expressing only one M protein family member. 
Courtney et al. (2009) also investigated if other emm-family proteins, M-related protein 
(Mrp) and M-like proteins (Enn) which also contribute to GAS adherence (Brouwer et al., 
2016), participated in LTA complex mediated biofilm formation. They found a significant 
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decrease in hydrophobicity, membrane-bound LTA, and biofilm formation relative to wild-
type using an isogenic mrp4 deficient GAS mutant of the emm4 expressing strain. 
However, an isogenic enn4 deficient GAS mutant was also examined and there was no 
difference in hydrophobicity, membrane-bound LTA, or biofilm formation compared to 
the wild-type. The M protein has previously been shown to be expressed at significantly 
higher levels than Mrp and Enn in a CS101 GAS (emm49) strain (Podbielski et al., 1995). 
Expression levels may play a part in the role of these proteins in LTA complex initiation 
and biofilm formation; however, this has yet to be determined. Collectively, this research 
highlights the need to study GAS biofilm formation using strains with diverse genetic 
backgrounds to understand the complex interplay between differing GAS virulence factors 
in the formation of GAS biofilms. 
Table 1.1. Summary of GAS biofilm studies assessing effect of different virulence factor and growth conditions on biofilm formation. The following molecules 
have been shown to contribute to GAS biofilm formation (BF): Lipoteichoic acid (LTA) and M protein (emm), M-related protein (Mrp), and M-like protein (Enn) 
complexes, pili, Streptococcal collagen like protein 1 (Scl-1), short hydrophobic peptides (SHP 1 and 2), the hyaluronic acid (HA) capsule, Group A Streptococcal 
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Figure 1.1. Role of GAS virulence factors in biofilm formation. Many bacterial surface molecules aid in 
the initial attachment of planktonic GAS to abiotic/biotic surfaces. This includes streptococcal collagen-like 
protein (Scl-1), pili, Group A Streptococcus protein A (AspA), as well as members of the M protein family 
such as the M protein and M-related protein, which form complexes with LTA to facilitate adherence (Cho 
and Caparon, 2005, Manetti et al., 2007, Courtney et al., 2009, Maddocks et al., 2011, Becherelli et al., 2012, 
Kimura et al., 2012, Oliver-Kozup et al., 2013, Bachert et al., 2016). Communication between bacteria utilises 
quorum sensing (QS) systems, secreting QS molecules such as streptococcal invasion locus protein (SilC), 
Short Hydrophobic Peptides (SHP) and  Autoinducer-2 (Al-2) of the streptococcal invasion locus (Sil), 
Regulatory gene of glucosyltransferase (Rgg), and LuxS/autoinducer-2 QS systems, respectively to facilitate 
adherence and maturation of biofilms which includes the production of the extracellular polymeric matrix 
(EPS) (Lembke et al., 2006, Thenmozhi et al., 2011, Aggarwal et al., 2014, Jimenez and Federle, 2014). 
Studies have also demonstrated strains that are encapsulated by hyaluronic acid do not form biofilm as readily 
as un-encapsulated strains, and it has been suggested that the hyaluronic acid capsule decreases biofilm 
forming capacity (Cho and Caparon, 2005, Sugareva et al., 2010, Marks et al., 2014).  Decreased transcription 
of the Streptococcal regulator of virulence has also been shown to increase production of SpeB, a cysteine 





Pili are long filamentous structures that exist on the surface of GAS, and numerous other 
bacterial species (Nakata et al., 2011, Young et al., 2016). Pili are encoded by the FCT 
(fibronectin-binding protein, collagen-binding protein, and trypsin-resistant antigen) 
genomic region of GAS. This is a highly variable 11kb pathogenicity island which 
contains genes for a pilus backbone protein, at least one matrix protein binding ancillary 
protein, sortases (SrtB/SrtC2), and a signal peptidase (Manetti et al., 2007, Köller et al., 
2010, Fiedler et al., 2015). GAS can be classified into nine FCT subtypes based on the 
diversity of gene content and nucleotide sequence (Kratovac et al., 2007, Falugi et al., 
2008, Kimura et al., 2012). Pili are identified as a major adhesin of GAS, and their 
involvement in the adherence of GAS to human tonsillar tissue, keratinocytes, lungs and 
throat epithelial cells has been characterised (Abbot et al., 2007, Crotty Alexander et al., 
2010, Smith et al., 2010). Numerous studies have demonstrated that pili play an integral 
part in GAS biofilm formation and have shown associations between several different 
FCT types and the capacity of GAS to form bacterial biofilms in vitro (Manetti et al., 
2007, Köller et al., 2010, Nakata et al., 2011, Ogawa et al., 2011, Kimura et al., 2012).  
Manetti et al. (2007) confirmed GAS FCT-2 pili are essential for efficient attachment of 
the GAS M1 strain SF370 to human epithelial cells as GAS pilus negative mutants, 
constructed by either deletion of the pilus backbone structural protein (Δspy0128) or the 




to epithelial cells. The same mutants did not efficiently aggregate in liquid culture and 
did not form the same amount of biofilm relative to the wild-type strain on polystyrene 
as determined by crystal violet biomass staining, or epithelial cells as observed by 
confocal microscopy (Manetti et al., 2007). The visualisation of the wild-type, Δspy0128 
and Δspy0129 strains demonstrated that the EPS was virtually absent for the mutant 
strains. This dramatically contrasted to the wild-type GAS SF370 strain and the 
complementation mutant for which the biofilm phenotype was restored. Together these 
results demonstrate that FCT-2 pili are important in transition to the biofilm phenotype 
for this SF370, and M1 serotype GAS strain. Following on from these findings, Köller et 
al. (2010) assayed biofilm formation, under an array of different growth conditions, for 
183 isolates that were emm and FCT-typed in an effort to demonstrate novel correlations 
between FCT-type and biofilm formation. Whilst novel associations between FCT-type 
and biofilm formation by multiple isolates was demonstrated, the data alone was 
inadequate to support a direct link between biofilm formation and FCT-type. This is most 
likely because there are many other virulence factors that play a role in biofilm formation 
by GAS. 
There are also data to suggest that the role of individual FCT-types in biofilm formation 
may be dependent on environmental conditions during infection. In a study of clinical 
isolates obtained from University Hospital in Rostock, Germany, between 2001 and 2006, 
an association between environmental conditions (acidity) and biofilm formation for 




surfaces and micro-colony formation on epithelial cells for FCT-types 2, 3, 5, and 6 and 
a subset of FCT-4 strains increased as a result of acidification caused by fermentative 
sugar metabolism. The subsequent decrease in environmental pH was associated with an 
enhanced expression of the pilus components and transcriptional regulators including the 
RofA-like protein (RALP) regulator family proteins RofA and Nra and the AraC/XylS 
type transcriptional regulator family protein, MsmR. Manetti et al. (2010) speculated that 
a decreased pH during colonisation at the cell surface due to sugar metabolism may favour 
biofilm formation; however, this requires further investigation, particularly to determine 
if this plays a role in the context of biofilm formation in the oropharynx. 
As an extension to the Köller et al. (2010) study that demonstrated emm type 6 strains 
with the FCT-1 type pili form high levels of biofilm in vitro, Kimura et al. (2012) 
characterised the role of FCT-1 pili in the GAS TW3558 (emm 6) strain. In-frame 
deletions of the pilus backbone (tee6), ancillary protein (fctX), and sortases (srtB and 
srtA) were used to produce isogenic pili deficient GAS mutants. Use of the mutants in 
biofilm growth assays demonstrated that deletion of the tee6 gene compromised the 
ability of the strain to form a biofilm on an abiotic surface, with deletion of fctX and srtB 
genes (pilus ancillary protein and class C pilus-associated sortase, respectively) further 
decreasing the capacity for biofilm formation. It was also noted that assembly of the pili, 
rather than individual pili components, are required for biofilm formation. The FCT-1 
pilus region (fctX operon) was then ectopically expressed in M1 strain SF370, and an 




biofilm formation. A similar study was conducted by Becherelli et al. (2012), whereby 
isogenic mutants of ancillary protein 1 (ALP-1) of FCT-1 type GAS were examined for 
biofilm formation. Wild-type bacteria produced substantial biofilms, whilst the mutant 
strain exhibited impaired biofilm forming capacity. Taken together, the data from 
Becherelli et al. (2012) and Kimura et al. (2012) suggests both structural, and assembly 
components of pili are important in adherence and biofilm formation of FCT-1 type GAS. 
However, the authors highlight that the role of pili should not be considered in isolation, 
as GAS biofilm formation is likely to be dependent on multiple factors (Kimura et al., 
2012).  
1.2.1.3. Streptococcal collagen-like protein 
Streptococcal collagen-like protein-1 (Scl-1) is expressed on the surface of GAS as a 
homotrimeric protein consisting of an N-terminal variable region, a collagen-like region 
containing Gly-X-Y repeats, and a cell-wall-anchored C-terminal region which contains 
a linker region connecting the collagen-like region to the cell wall and membrane 
associated portions of the protein (Lukomski et al., 2000, Xu et al., 2002, Oliver-Kozup 
et al., 2013). Transcription of Scl-1 is positively regulated by multiple gene activator 
regulons, suggesting it may be co-expressed with many other GAS virulence factors such 
as the M protein family (Oliver-Kozup et al., 2011). Scl-1 is present within all strains of 
GAS and regarded as a major cell surface adhesin (Lukomski et al., 2000, Xu et al., 2002). 
It is also recognised as a contributor to the biofilm forming capacity of GAS on abiotic 




capacity for adhesion and biofilm development, as well as variation in surface 
morphology and EPS production (Oliver-Kozup et al., 2011). In this study by Oliver-
Kozup et al. (2011), the expression of the Scl-1 protein in a heterologous Lactococcus 
lactis (L. lactis) system facilitated biofilm formation, further implicating this protein in 
biofilm production. Results from a study by Bachert et al. (2016) assayed biofilm 
formation in M3 GAS, supported these earlier findings. They introduced a nonsense 
mutation into the scl1 coding sequence, which reduced the transcription of the gene in the 
M3 GAS. Biofilms grown using this mutant on abiotic surfaces coated with fibronectin 
and laminin exhibited a significantly reduced capacity to form a biofilm. Moreover, the 
M3 GAS mutant was not able to form micro-colonies when introduced into a skin 
infection model. When the nonsense mutation was repaired, restoration of expression 
increased biofilm formation upon fibronectin and laminin surfaces (Bachert et al., 2016). 
1.2.1.4. Hyaluronic acid capsule 
The hyaluronic acid (HA) capsule, a major virulence factor of GAS, is highly conserved 
and surface-exposed, and made from a polymer of repeating units of glucuronic and N-
acetylglucosamine (Stoolmiller and Dorfman, 1969). Some studies suggest that HA is an 
adhesin that aids in the attachment of GAS strains to host cells (Schrager et al., 1998, 
Cywes et al., 2000). Conversely, it has been reported that HA capsule can decrease 
streptococcal adherence by preventing the surface-exposed adhesins from attaching to 
host cell receptors (Bartelt and Duncan, 1978). The capsule is also central to immune 




greater propensity for virulence than those with a reduced/absent capsule (Henningham 
et al., 2014). Investigations into the role of capsule in GAS biofilm formation have 
implicated HA in biofilm maturation. When Cho and Caparon (2005) assessed the biofilm 
forming capacity of a wild-type HSC5 GAS (M5) strain and an isogenic capsule deficient 
mutant whereby the hyaluronate synthase (HasA) gene was abolished, they found the 
biofilm forming ability of the mutant was not affected under static conditions. This 
suggests HA does not affect the initial bacterial attachment that is required for subsequent 
biofilm formation. To illustrate the role of HA in later stages of biofilm maturation, flow 
chambers were utilised, and although the mutant was able to adhere to the surface of the 
chamber it was unable to propagate the biofilm phenotype and cells seemed to appear 
dispersed across the substratum evenly, suggesting that HA has a role in biofilm 
maturation (Cho and Caparon, 2005). A more recent study observed a decrease in HasA 
transcription in biofilms of MGAS315 (emm 3) grown on live keratinocytes (SCC13) in 
comparison to planktonic bacteria. Marks et al. (2014) suggested other factors (e.g. the 
host environment) must affect the role of HA in biofilm formation. Indirect evidence that 
the amount of capsule inhibits GAS biofilm formation was reported by Sugareva et al. 
(2010). CovS is a sensor kinase involved in regulation of hyaluronic acid synthesis. 
Deletion of CovS was shown to lead to increased capsule production but lower biofilm 
biomass for emm 2, 6, 18, and 49. Furthermore, Sugareva et al. (2010) suggested strains 
with less HA seem to form biofilm more readily. It could therefore be suggested that the 




facilitate biofilm maturation. Overall, the role of HA in GAS biofilms has yet to be fully 
elucidated. 
1.2.1.5. Streptococcal antigen I/II  
Most oral streptococci express streptococcal antigen I/II (Agl I/II) family polypeptides, 
which have demonstrated roles in adhesion to human salivary glycoproteins, other 
microbial cells, and calcium to facilitate colonisation in the oral cavity (Jenkinson and 
Demuth, 1997, Maddocks et al., 2011). An Agl I/II polypeptide produced by M28 GAS 
called Group A Streptococcus protein A (AspA) has been shown to have a role in biofilm 
formation in two independently isolated M28 serotypes (Maddocks et al., 2011). Deletion 
of the aspA gene in these strains abolished their ability to propagate the biofilm phenotype 
on saliva-coated surfaces. The biofilm developing capacity of the strain was reinstated 
upon trans-complementation of the aspA deletion. Additionally, expression of the AspA 
protein in L. lactis allowed for biofilm development in this species, relative to wild-type 
L. lactis. Whilst AspA is a relatively understudied GAS virulence factor, these results 
indicate AspA plays a role in adhesion and biofilm propagation in GAS. 
1.2.1.6. Regulators of gene expression in GAS biofilms 
The Streptococcal regulator of virulence (srv) is a transcriptional regulator required for 
GAS virulence, as it controls the transcription of many extracellular proteins (Reid et al., 
2006, Doern et al., 2008). There is also some evidence indicating participation of this 




and its complementation mutant were used to demonstrate that srv-mediated transcription 
is an important contributor to biofilm formation (Doern et al., 2009). A decreased capacity 
to form a biofilm was observed for the Srv deficient strain which was restored to levels 
comparable to the wild-type strain following complementation. It was suggested that srv 
may control transcription of genes necessary for adherence and micro-colony formation. 
One of the extracellular proteases controlled by srv is the cysteine protease SpeB (Doern 
et al., 2009). In the absence of Srv, over-production of SpeB is associated with decreased 
biofilm formation (Doern et al., 2009). Complementation decreased SpeB production and 
restored biofilm formation comparably to the wild-type. This suggests that SpeB may 
degrade the components required for biofilm formation and could play a role in 
dispersion, however, further investigation is required. 
1.2.2. Quorum sensing 
Quorum sensing (QS), a hallmark feature of many bacterial biofilms, has also been noted 
for GAS biofilms. Three GAS QS systems have been described: streptococcal invasion 
locus (Sil), regulatory gene of glucosyltransferase (Rgg), and LuxS/autoinducer-2.  
Sil has been linked to regulating genes involved in invasive disease (Jimenez and Federle, 
2014). SilC is a signaling peptide of Sil, and has been linked to the ability of GAS to 
spread in soft tissues (Belotserkovsky et al., 2009). Importantly, SilC has been shown to 
have a role in QS for GAS biofilm formation (Lembke et al., 2006, Thenmozhi et al., 
2011). Using safranin-staining, an isogenic emm14 silC mutant showed reduced 




relative to the wild-type strain, but this was not statistically significant (Lembke et al., 
2006). An isogenic emm18 silC mutant exhibited reduced adherence to collagen type I 
and IV substrates, relative to the wild-type strain, but this was also not statistically 
significant. SEM analysis of the emm14 and emm18 silC mutants revealed phenotypic 
changes in the strain relative to the wild-type. The emm14, silC mutant biofilm surface 
displayed more clefts than the wild-type analogue whilst the emm18 silC mutant 
displayed a thinner biofilm with a patchy appearance, whilst its wild-type comparator 
presented a solid and thick biofilm (Lembke et al., 2006). 
Conversely, in a study by Thenmozhi et al. (2011), it was suggested that strains from 
different serotypes form biofilms regardless of the presence of the silC gene. Crystal 
violet staining of biofilms grown from strains of 11 different serotypes distinguished 
M56, M65, M74, M89, M100, and st38 as biofilm formers and M49, M63, M88.3, M122, 
and st2147 as non-biofilm formers. These biofilms were grown under static conditions on 
uncoated polystyrene. These strains were screened for the presence of silC which was 
found present in only M100, M74, and st38 from the biofilm formers and the non-biofilm 
former M122. Serotypes lacking silC were the most proficient biofilm producers under 
these conditions suggesting that the involvement of SilC in quorum sensing is not required 
for biofilm formation in all strains. 
The Rgg QS system is one of the most conserved systems among Firmicutes, universally 
existing among all species of Streptococcus. Within this large family of regulatory 




virulence is controlled by the Rgg2/Rgg3 system in response to the short hydrophobic 
peptides SHP2 and SHP3 (Chang et al., 2011). The effects of SHP have been witnessed 
in GAS biofilm development with potentiation of surface-associated biofilms forming in 
concentrations of synthetic SHP pheromone as low as 5 nM (Aggarwal et al., 2014). Rgg-
SHP-mediated QS has also been hypothesised to promote interspecies signaling between 
common residents of the nasopharynx; S. pneumoniae, S. dysgalactiae, and GAS (Chang 
et al., 2011). Interspecies signaling utilising the orthologous Rgg/SHP systems has been 
further investigated and shown to be bidirectional between GAS, GBS, and Streptococcus 
dysgalactiae subsp. equisimilis, however, the implication for the role of this particular 
bidirectional communication using QS systems in multispecies biofilm formation and 
virulence warrants further analysis (Cook et al., 2013).  
Lastly, Autoinducer-2 synthesised by LuxS, an enzyme present in several biofilm forming 
bacteria, including GAS, is necessary for biofilm formation (Jimenez and Federle, 2014). 
Although this QS system has yet to be thoroughly investigated, it is thought to control 
some virulence mechanisms (haemolytic and proteolytic activity), and importantly emm 
gene expression and SpeB production, which have both been shown to affect biofilm 
formation and development (Lyon et al., 2001, Marouni and Sela, 2003, Siller et al., 2008, 
Beema Shafreen et al., 2014). 
1.3. Modelling GAS biofilms 
Current knowledge of biofilm formation, including basic hallmark characteristics, 




modelling. In vitro models aim to depict conditions similar to those in vivo considering 
variables such as growth rate, flow rate, nutrient availability, gas concentrations, and 
substratum. The simplest and earliest biofilm model was liquid growth media inoculated 
with bacteria left to colonise the solid surface (Zobell, 1943). However, higher throughput 
models have since been developed such as multi-well systems using various abiotic 
growth surfaces (glass, plastic, silicone, and polystyrene). Although these are cost-
effective and somewhat easy to implement, the biofilms formed are limited in their ability 
to truly mimic those in an in vivo setting (Marks et al., 2014). Moreover, while in vitro 
GAS biofilms have provided important insight into GAS biofilm formation, GAS 
colonisation and infection in vivo is a complex process involving multiple interactions 
with the host. Such interactions initiate and alter GAS gene expression in a way that is 
difficult to mimic in most in vitro models. It has been demonstrated that a lack of host 
factors resulted in highly differential virulence gene expression between biofilms 
produced in vitro to those present in vivo (Cho and Caparon, 2005), highlighting the 
importance of mimicking the host environment as closely as possible. Alternative 
approaches to biofilm formation include the use of epithelial cells as a substratum for 
GAS biofilm growth to compensate for host factor presence. However, the inherent 
toxicity of broth grown GAS strains renders long term biofilm-epithelial modelling 
difficult (Håkansson et al., 2005). A more recent study that utilised both live and pre-
fixed epithelial substrata successfully integrated aspects of the necessary environment, 




able to form micro-colonies, resemblant of biofilms in vivo, as opposed to dense biofilm 
sheets typical of biofilms grown on abiotic surfaces. Additionally, biofilms were non-
toxic to the live human keratinocyte substratum. Overall, this study confirmed that an 
epithelial substratum potentiates biofilm formation, with bacterial morphology 
resemblant of in vivo GAS biofilms, a result not achievable for GAS biofilms grown on 
abiotic surfaces like glass or plastic (Marks et al., 2014). Another in vitro study 
investigated the ability of 2 dominating emm-types involved with NSTI, (emm 1 strain 
8157, and emm 3 strains 5626 and 8003) to form biofilms using standard polystyrene and 
glass surfaces (Siemens et al., 2016). Both emm 3 strains formed biofilms on uncoated 
and fibronectin-coated polystyrene surfaces. In contrast, only strain 5626 was able to form 
a biofilm on glass surfaces. The emm 1 strain 8157 did not form biofilms under the tested 
plate conditions. A 3D organotypic skin model was also generated using human 
keratinocyte cells (N/TERT-1) and normal human dermal fibroblasts (NHDF) to mimic 
key anatomical/functional features of the skin. This model had the advantage of dermal 
and epidermal layers being formed, and key epidermal structural proteins included. The 
emm 1 strain 8157, and emm 3 strains 5626 and 8003 were all able to initiate tissue 
infection in this model, and after 8 hours of incubation, the bacteria were found to 
predominate the stratum cornium. Upon further incubation the bacteria were dispersed 
throughout the whole tissue, with bacterial aggregates that developed typical of biofilm 
upon immunostaining. Further investigation of these aggregates utilising confocal laser 




including exopolysaccharides, lipids, and extracellular DNA associated with the bacterial 
community (Flemming and Wingender, 2010, Siemens et al., 2016). At present, GAS 
existing in the biofilm phenotype is not recognised as a potential component of NSTIs. 
This comprehensive study by Siemens et al. (2016) supports the need for further 
investigation into the role biofilms play in GAS NSTIs, and by extension, other GAS 
associated skin infections.  
Future studies using similar epithelial-GAS biofilm models are necessary, with a focus 
on establishing the interaction between GAS and the local host environment to provide a 
more accurate understanding of the underlying mechanisms in which GAS may adhere, 
colonise and persist in the host. Whilst much of the work has focused on the role of host 
proteins in GAS biofilm formation, host glycans are yet to be studied in the context of 
GAS biofilm formation. 
1.4. Glycans in bacterial pathogenesis   
Glycans are carbohydrates present on more than half of all human proteins, with their 
ubiquitous presence in mucosal fluid, on secreted molecules, immune cells, and a variety 
of epithelial cell surfaces, making glycosylation one of the most common post-
translational modifications (Apweiler et al., 1999, Christiansen et al., 2014).  
Glycans exist as saccharides attached to a lipid or protein backbone, they can be linear or 
branched, and consist of monosaccharides linked glycosidically (Belický et al., 2016). 
Glycans can occur either as N- or O-linked and are distinguished by the amino acids they 




glycans attached at the oxygen of serine or threonine amino acid residues (Fig 1.2) 
(Belický et al., 2016).  
 
Figure 1.2. Glycoprotein and its O- and N-linked glycans. The simplified diagram depicts a protein 
backbone (blue) decorated with O- and N-linked glycans attached at serine (Ser)/threonine (Thr) or 
asparagine (Asn) residues respectively.  
Glycans have several important biological roles; structural and modulatory roles (e.g. 
protein folding and membrane organisation), intrinsic intra-species roles (e.g. immune 
recognition via self-associated molecular patterns), and extrinsic inter-species host-
pathogen roles (e.g. pathogen-associated molecular patterns and immune modulation of 
host by pathogen) (Varki, 2016).  
The host cell surface is a landscape rich in an assortment of glycan structures, with access 
to these glycans making for an interesting and complex environment for pathogens to 
bind and utilise for a variety of purposes. Within the last decade, considerable 
advancements have been made in the field of glycobiology such as the development of 
lectin and glycan microarrays that provide high-throughput screening with increased 
sensitivity and accuracy. These technologies have enabled the unveiling and 
identification of these novel glyco-interactions occurring at the bacterial-host interface 




the host for many bacteria, mediating attachment and colonisation, and can consequently 
facilitate infection and disease (Poole et al., 2018). Despite the growing evidence and 
appreciation of the role glycans play in the pathogenesis of several bacteria (Poole et al., 
2018), investigation into glycans and their involvement in mediating GAS disease 
remains comparatively under-investigated.   
1.4.1. Glycans are implicated in bacterial adherence at the oropharynx 
The oropharynx comprising of the oral cavity and contiguous regions of the tonsils, 
pharynx, and oesophagus, together the tissues of these distinct sites have a cumulative 
role in both human health and disease (Dewhirst et al., 2010). The oropharynx further 
connects to the respiratory and gastrointestinal tract, and as such it is a critical port of 
entry for several pathogens. Hence, considerable efforts have been made into 
understanding the interplay between both the naturally residing microflora and 
pathogenic bacteria to the glycoproteins of saliva and the oropharyngeal epithelia as a 
means of mediating host-microbe interactions in both healthy and diseased states (Poole 
et al., 2018). 
Saliva is a protein rich liquid environment that bathes the oropharynx, and it contains a 
variety of protein families (e.g. salivary amylase, mucins, agglutinin, basic and acidic 
proline rich proteins, immunoglobulins etc), many of which are heavily glycosylated 
(Helmerhorst and Oppenheim, 2007). Mucins are an example of a glycan rich protein 
predominated by O-linked (and some N-linked) glycans, and have a considerable role in 




bacteria, fungi, and viruses have been found to use lectin-like adhesins to adhere to these 
salivary mucins. Helicobacter pylori is a prime example of a well characterised 
pathogenic bacteria that has demonstrated effective binding to Lewis B glycan motifs on 
a major salivary mucin, MUC5B, which otherwise has important roles in host defense. It 
is hypothesised that this binding mechanism employed by H. pylori enables it to 
camouflage from host defense via molecular mimicry, where it can successfully migrate 
from the oral cavity to its preferred site of colonisation, the stomach. Once established in 
the stomach, H. pylori causes a variety of gastrointestinal diseases such as peptic ulcers 
and gastritis (Walz et al., 2005, Issa et al., 2010).  
Similarly, attachment to host tissues at the oropharynx is also in part mediated by glycans. 
The diversity of the glycans that cover the oropharynx has been thought to contribute to 
distinct tissue tropisms of microbes, sometimes leading to site specific colonisation and 
infection even within spaces of close proximity (e.g. differential microfloral colonisation 
of the tooth versus microbial communities present at the tongue) (Cross and Ruhl, 2018). 
This is particularly evident for Streptococcus mutans which exclusively colonises the 
tooth surface via agglutinin binding, where it consumes a variety of monosaccharides 
(e.g. mannose, fructose, lactose, and galactose) available at the site. Metabolised 
monosaccharides are converted into acids that accumulate and cause considerable dental 
decay, carries, and disease (Mitchell, 2003).  
Streptococcus pneumoniae is another well-characterised member of the streptococci 




S. pneumoniae expresses several glycosidases that facilitate both adherence and 
modification of a variety of glycan structures (glycosaminoglycans and both N- and O-
linked glycans) of the airway. Given the prevalence of sialic acid in the oronasopharynx, 
it is perhaps unsurprising that S. pneumoniae is equipped with three neuraminidases 
(NanA, NanB, and NanB), each of which sequentially cleave terminal sialic acid residues 
off mucosal glycan structures. Liberated sialic acid is utilised by S. pneumoniae for 
metabolic consumption as well as successful pneumococcal adherence, colonisation, and 
subsequent disease (King, 2010).    
Several other pathogens (e.g. Candida albicans, P. aeruginosa, and E. coli) involved in 
a variety of mild to severe infections and diseases have been found to bind glycans of the 
oropharynx (Lewis and Lewis, 2012, Everest-Dass et al., 2017, Olsen, 2020). Taken 
together, these findings cement the importance of host glycans in mediating microbial 
pathogenesis in oropharyngeal disease.  
1.4.2. Glycans in GAS adherence 
GAS possesses several adhesins and virulence factors (previously outlined) that are 
important in mediating initial bacterial attachment and adherence to the epithelial surfaces 
of the throat and skin. Exploitation of host cell surface glycans is a recognised component 
that drives pathogenesis for several microbes (Poole et al., 2018). However, the 
investigation into glycan binding and utilisation by GAS is comparatively underexplored. 




the adhesin-like properties of M protein, a major surface expressed protein and virulence 
factor of GAS (Frick et al., 2003, De Oliveira et al., 2017, De Oliveira et al., 2019).  
1.4.2.1. M protein is implicated in glycan binding  
The M protein is a highly expressed virulence factor of GAS, and it is implicated in 
adherence (Walker et al., 2014). Due to its preeminence, the M protein has been of 
primary focus for identifying GAS-host glycan interactions, and efforts to characterise 
these interactions continue to be explored.  
Some of the earliest research has been conducted on glycosaminoglycans (GAGs) as 
targets for M protein binding (Bergey and Stinson, 1988, Wadstrom and Ljungh, 1999, 
Frick et al., 2003). GAGs are abundantly present in the extracellular matrix of all 
eukaryotic surfaces, and have been recognised as binding points for several bacteria, 
viruses, and protozoa (Wadstrom and Ljungh, 1999). Bergey and Stinson (1988) found 
exogenous GAGs, heparin, and heparin sulfate when added in excess, acted as 
competitive inhibitors of M6 GAS serotype binding to heparin natively present on the 
basement membranes of kidney tissue samples. Other GAGs were similarly assessed 
(dermatan sulfate, chondroitin sulfate, and hyaluronic acid), with inhibition of GAS 
binding occurring to a lesser degree. Wadstrom and Ljungh (1999) described heparin 
binding to GAS surface molecules, albeit at a low affinity, which they attributed to non-
specific binding arising from various charged molecules reducing opportunities to bind 
heparin. However, only recently was the M protein determined as the adhesin binding 




from 49 GAS serotypes to associate with various pharyngeal- and dermal-associated 
GAGs (including heparin, heparin sulphate, and dermatan sulphate). The study concluded 
that GAGs mediated GAS adhesion to human cells in an M protein-dependent manner 
(Frick et al., 2003). 
M protein has also been shown to bind other glycans. A study of a throat tropic M6 GAS 
strain found that fucose containing glycoproteins were essential for M-mediated GAS 
adherence to pharyngeal epithelia (Wang and Stinson, 1994). More recently, De Oliveira 
et al. (2019) have shown differential GAS binding affinities of three pharyngitis 
associated GAS serotypes M1, M3, and M12 towards ABO(H) blood group antigen 
glycan structures are underpinned by differences in M protein affinity towards blood 
group antigen structures.   
Taken together, these data suggest M protein has an important role in mediating GAS-
host glycan interactions and could serve as a potential avenue for therapeutic targeting in 
the form of glycomimetics that block GAS adherence. 
1.4.3. Glycans in oropharyngeal biofilm formation 
The oropharynx and its epithelial cell surfaces, mucosal layers, immune cells, secreted 
molecules, and the saliva which bathes the entirety of the oropharynx are heavily 
glycosylated. Microbes utilise and modify these glycans for metabolic processes, 
microbial growth, crossing mucosa, and deactivation/reducing the activity of host 
immune molecules (Collin and Olsén, 2001, Iyer and Camilli, 2007, Lewis and Lewis, 




microbial attachment and adherence, both crucial initiatory steps towards biofilm 
formation and biofilm establishment within the host.  
S. pneumoniae, an opportunistic pathogen of the oronasopharynx, is perhaps the most 
characterised for its interactions with host glycans and subsequent biofilm forming 
abilities. Several reports have suggested that glycan modification and utilisation are 
necessary mechanisms in biofilm formation for pneumococcal colonisation (King, 2010, 
Lewis and Lewis, 2012). Although it is likely to be a multifactorial process, the ability of                        
S. pneumoniae to form biofilms has been attributed to glycosidase action exerted by 
neuraminidases NanA and NanB, both of which cleave and liberate sialic acid residues 
abundantly present in the pharynx and airway of the host (Parker et al., 2009, Lewis and 
Lewis, 2012). One study found that S. pneumoniae nanA and nanB mutant strains 
displayed diminished biofilm forming abilities in vitro (Parker et al., 2009). NanA and 
NanB were further implicated in biofilm formation in a study by Trappetti et al. (2009) 
which found that initial adherence to the well surface increased only in the presence of 
sialic acid, and the other 26 sugars assessed exerted no effect. The study further found 
that biofilm increased in the presence of exogenous sialic acid, with biofilm forming 
abilities diminishing upon the addition of sialic acid analogs or inhibitors of the 
neuraminidases tested. Another study described NanA to be particularly active during 
cluster formation and biofilm maturation in vitro (Parker et al., 2009). Thus, host glycans 
play an important role in the various stages of biofilm formation for S. pneumoniae. Other 




and Haemophilus influenza have been known to exploit and be dependent on sialic acid 
for biofilm formation (Bouchet et al., 2003, Roy et al., 2011, Li et al., 2012). Taken 
together, it is evident that glycans of the oropharynx are an important component of 
microbial adherence and subsequent biofilm formation. However, the role of host glycans 
in the context of GAS biofilm formation is an area of research that has previously 
remained unexplored.  
1.5. Aims and Objectives 
Despite GAS remaining sensitive to penicillin, antibiotic treatment failure rates of 20-
40% have been reported. GAS biofilm formation has previously been investigated in the 
context of virulence factor involvement using models that do not effectively mimic the 
host. Improved models of GAS biofilm formation that utilise host factors to mimic in vivo 
conditions will ensure biofilms generated in the lab more accurately reflect those 
occurring during a clinical infection.  
Moreover, host glycans have been implicated in planktonic GAS adherence. However, it 
is clear that there is gap in the field surrounding their role in GAS biofilm formation. 
Improved understanding of the way in which GAS interacts, and forms biofilms at the 
GAS-tissue interface will enhance our understanding of GAS biofilms and pathogenesis.  
As such, the aims of this project were to investigate the role pharyngeal cell surface 




Specifically, the aims of this project were to: 
I. Develop and optimise a GAS biofilm-host cell model 
II. Assess the role pharyngeal cell surface glycans play in throat tropic M12 GAS 
biofilm formation 
III. Assess the role pharyngeal cell surface glycans play in GAS biofilm formation for 




Chapter 2: Developing and optimising a GAS biofilm-host cell 
model  
A part of this work has been published in Scientific Reports, Nature. 
Overview: GAS causes 700 million infections and accounts for half a million deaths per 
year. Biofilm formation has been implicated in both pharyngeal and dermal GAS 
infections. In vitro, plate-based assays have shown that several GAS M-types form 
biofilms, and multiple GAS virulence factors have been linked to biofilm formation. 
Although the contributions of these plate-based studies have been valuable, most have 
failed to mimic the host environment, with many studies utilising abiotic surfaces. GAS 
is a human specific pathogen, and colonisation and subsequent biofilm formation is likely 
facilitated by distinct interactions with host tissue surfaces. As such, a host cell-GAS 
biofilm model has been optimised to support and grow GAS biofilms of a variety of GAS 
M-types. Improvements and adjustments to the crystal violet biofilm biomass assay have 
also been tailored to reproducibly detect delicate GAS biofilms. 72 h was determined as 
an optimal growth period for yielding detectable biofilm biomass. Using the established 
method, GAS biofilms formed are robust and durable, and can be reproducibly assessed 
via staining/washing intensive assays such as crystal violet with the aid of methanol 
fixation prior to staining. Lastly, SEM imaging of GAS biofilms formed by this model 
are resemblant of those previously found on excised tonsils of patients suffering chronic 
pharyngo-tonsillitis. Taken together, an efficacious GAS biofilm host-cell model has been 
developed that can support long-term GAS biofilm formation, with biofilms formed 





GAS is a Gram-positive human pathogen known to cause an array of infections ranging 
from mild infections of the skin and throat, to more serious and life threatening conditions 
such as necrotising fasciitis and numerous autoimmune sequelae (Walker et al., 2014). 
GAS poses a considerable global burden, with high rates of patient mortality and 
morbidity (Carapetis et al., 2005). 
GAS has been found to form biofilms in the tonsillar crypts of GAS pharyngitis 
tonsillectomy patients, and in the skin lesions of GAS impetigo sufferers (Akiyama et al., 
2003, Roberts et al., 2012). In vitro, it has been demonstrated that GAS biofilm formation 
is strain dependent. Among isolates of the same serotype, biofilm forming capacities are 
oftentimes found to differ considerably (Baldassarri et al., 2006). Furthermore, in vitro 
plate-based studies have implicated several GAS virulence factors (M protein, capsule, 
pili, SpeB, CovS, and quorum sensing peptides) in biofilm formation (Vyas et al., 2019). 
These findings have contributed substantially to our current understanding of GAS 
biofilms and their involvement in GAS pathogenesis and disease. However, much of this 
work has been conducted on abiotic surfaces (plastic, glass, and silicone) which GAS 
does not naturally colonise. To date, few studies have used host matrix components like 
collagen, fibronectin, or fibrinogen as surface coatings (Cho and Caparon, 2005, Lembke 
et al., 2006, Sugareva et al., 2010, Oliver-Kozup et al., 2013). Moreover, there is currently 
no gold standard methodology or protocol in the GAS field for biofilm formation. The 
variability among methods, and limited use of host factors in in vitro plate-based GAS 
biofilm models found in previous studies has been summarised in Table 2.1. This table 
highlights that only three in vitro plate-based studies utilising epithelial monolayers to 




There is a need for GAS biofilm models to better incorporate host factors, as it has been 
found that failure to do so has significant effects on the biofilms formed, with the overall 
arrangement and architecture of biofilms and their virulence gene expression, found to 
noticeably differ from that of biofilms formed in vivo (Cho and Caparon, 2005). 
Moreover, tissue tropism displayed by differing GAS isolates towards the throat and skin, 
which are vastly different epithelial landscapes and environments (Bessen and Lizano, 
2010), will influence GAS adherence, colonisation, and subsequent biofilm formation. 
Thus, the incorporation of relevant host epithelial substratum, and an overall mimicking 
of the host environment should be a consideration in GAS biofilm modelling.  
Here, a GAS-pharyngeal cell model has been optimised to cultivate robust 72 h GAS 
biofilms that can be used for a diverse set of GAS M-types. We also propose some 
optimised steps and tips for increased biofilm integrity and reproducibility when 
performing crystal violet staining assays. This model has since been used to effectively 
assess the role pharyngeal cell surface glycans play in GAS biofilm formation (Vyas et 
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*Inoculums listed as ratios (bacteria: bacterial media), growth phase, or optical density. 
2.2. Materials and methods  
2.2.1. GAS and culture conditions 
GAS strains used in this study (Table 2.2) are clinical GAS isolates, with each strain 




et al., 2004, Sanderson-Smith et al., 2014). GAS was grown on horse blood agar (HBA) 
plates (Oxoid, UK) or Todd Hewitt agar supplemented with 1% (w/v) yeast (THYA) 
(Difco, Australia) (for media compositions see Appendix A). Static cultures of GAS were 
grown overnight in Todd Hewitt broth supplemented with 1 % (w/v) yeast (THY) (for 
enumeration (CFU/mL) details of GAS overnight cultures see Appendix B). GAS was 
cultured and maintained at 34°C (Marks et al., 2012). 
Table 2.2. GAS strains utilised in this study, their emm-types, and clinical source  
(Johnson et al., 2002, Aziz et al., 2004, McKay et al., 2004, Sanderson-Smith et al., 2014, De Oliveira et al., 
2019). 
M-type Strain Clinical source 
M1 5448 Invasive infection: Necrotising fasciitis and toxic shock 
M12 PRS-8 Superficial infection: persistent Pharyngeal pus/sinusitis 
M3 90254 Invasive infection 
M98 NS88.2 Invasive infection: Blood (bacteraemia) 
M108 NS50.1 Superficial infection: Wound 
2.2.2. Human pharyngeal cell culture conditions  
Detroit 562, a human pharyngeal epithelial cell line (CellBank Australia, Australia), was 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) F12 (Invitrogen, Australia), 
supplemented with 2 mM L-glutamine (Gibco, Life Technologies, UK) and 10 % (v/v) heat 
inactivated foetal bovine serum (FBS) (Bovogen Biologicals, Australia) in cell culture 
flasks at 37˚C, 5% CO2 – 20% O2 atmosphere. For tissue culture cell media composition 
see Appendix A. 
2.2.2.1. Pharyngeal cell monolayer formation  
Fixed Detroit 562 pharyngeal cell monolayers form the substratum for GAS biofilm 
growth. An outline of the optimised process and the monolayers formed are as depicted in 
Fig 2.1. Firstly, the wells of a 96-well flat bottom cell culture microtiter plate (Greiner Bio-
One, Germany) was coated with 50 µL of 300 µg/mL Collagen I from rat tail (Gibco, Life 
Technologies, UK) prepared in pre-chilled, sterile 17.4 mM acetic acid solution. The plate 




After 1 h, the excess collagen was removed from the wells and the wells were seeded with 
150 µL Detroit 562 cell suspension (2x105 cells/mL) and cultured for 48 h (achieving ~95% 
confluency). Once a ~95% confluent Detroit 562 pharyngeal cell monolayer was achieved, 
the media containing debris/non-attached Detroit 562 cells was removed, and the wells 
washed once with 200 µL of phosphate buffer solution (PBS) (for buffer compositions see 
Appendix A). The Detroit 562 pharyngeal cell monolayers were then fixed with 50 µL 
sterile 3.7% paraformaldehyde (PFA) (Sigma-Aldrich, USA) for 20 min (RT). Once fixed, 
the PFA was removed and the monolayers were washed twice with 200 µL of PBS. 
Monolayers can be used immediately or stored at 2-8°C for up to two weeks (with 
monolayers kept wet via submersion in 200 µL of PBS) until required for use.  
 
Figure 2.1.   Schematic outlining the optimised process of Detroit 562 pharyngeal cell monolayer 
formation. Schematic shows collagen coating, seeding with Detroit 562 pharyngeal cells, and finally an 
example well containing a 3.7% PFA fixed ~95% confluent monolayer of Detroit 562 pharyngeal cells. 
Example monolayer image taken at 10x objective at the Incucyte. 
2.2.3. GAS biofilm formation  
An outline of the optimised process for GAS biofilm formation using the GAS-pharyngeal 
cell model is as depicted in Fig 2.2. Wells containing fixed pre-formed Detroit 562 
pharyngeal cell monolayers were inoculated with 150 µL of overnight GAS culture diluted 




THY-G (no bacteria) served as media sterility controls and blanks. The plate was incubated 
for 2 h (34°C, 50 rpm) to facilitate GAS interaction and adherence to the pharyngeal cell 
monolayer substratum. At 2 h, non-adhered GAS was removed, and the wells replenished 
with 150 µL sterile THY-G media and the plate incubated (34°C, 50 rpm). Every 24 h, the 
media was refreshed with 150 µL sterile THY-G until a robust 72 h GAS biofilm was 
formed. 
 
Figure 2.2.   Schematic outlining the optimised process of GAS biofilm formation upon the fixed 
Detroit pharyngeal cell monolayers. Schematic shows fixed Detroit 562 pharyngeal monolayers co-
cultured with planktonic GAS cells (cocci chains) left to adhere for 2 h. 72 h GAS biofilms are formed 
directly from adhered GAS. 
2.2.4. GAS biofilm biomass crystal violet staining 
Biofilms were detected for their biomass via crystal violet staining modified from Burmølle 
et al. (2006) and Barraud et al. (2012). To do so, the media was gently and slowly pipetted 
off from the biofilms formed, and thoroughly air dried (30-40 mins, or until fully dried). 
Dried biofilms were fixed with 150 µL of 99% methanol for 15 min as per Peeters et al. 
(2008). Once fixed, the methanol was removed, and the biofilms were further thoroughly 
air dried to evaporate any remnant methanol. Biofilms were then stained with 150 µL of 
0.2% crystal violet (w/v) (Sigma-Aldrich, USA) supplemented with 1.9% ethanol (v/v) for 
10 min (RT, static). Upon staining, excess crystal violet was removed, and the biofilms 
gently washed twice with     200 µL of PBS. Crystal violet stain that had incorporated into 




(SDS) (w/v) (Sigma-Aldrich, USA). To ensure thorough release of the crystal violet stain, 
the biofilms were left to de-stain in the SDS solution for 10 min (RT, static). Monolayers 
with THY-G (no GAS biofilm) served as plate blanks. Resultant released crystal violet stain 
was diluted 1:5 in 1% SDS solution and biofilm biomass determined 
spectrophotometrically at OD540nm (SpectraMax Plus 384 microplate reader). 
2.2.5. Scanning electron microscopy 
M1 and M12 GAS biofilms were grown on Detroit 562 pharyngeal cell monolayers pre-
formed on 13 mm plastic Nunc Thermanox coverslips (Proscitech, USA) in a 12-well 
polystyrene plate. Biofilms were air dried, and prepared for SEM using methods adapted 
from (Williams and Bloebaum, 2010) with the following modifications. In brief, biofilms 
were pre-fixed in 2.5% glutaraldehyde, 50 mM L-lysine monohydrochloride, and 0.001% 
ruthenium red solution prepared in 0.1 M HEPES buffer (pH 7.3) (30 min, 4°C). 
Following pre-fixation, biofilms were fixed in fixative solution (2.5% glutaraldehyde and 
0.001% ruthenium red prepared in 0.1 M HEPES buffer, pH 7.3) for 1.5 h (4°C) and 
washed twice in 0.1M HEPES buffer. 2% osmium tetroxide vapour was used post-
fixation (2 h) followed by three washes with distilled water (each 15 mins). A graded 
ethanol series (30%, 50%, 70%, 90%, and 3x 100%) was then used to remove all water 
from the biofilms before they were critical point dried (Leica CPD 030, Austria). Dried 
biofilms were then sputter coated with 20nm platinum (Edwards Vacuum coater, USA) 
and visualised using a JEOL JSM-7500 microscope (JEOL, Japan) at 15 000 x 
magnification. Detroit 562 pharyngeal monolayer controls (without biofilms) were also 
imaged at 5000 x magnification. Images were taken at random positions within the 
samples by an UOW Electron Microscopy Centre technician blinded from the study in an 




2.2.6. Statistical analysis 
All statistical analysis was performed using GraphPad Prism (version 8.4.0, GraphPad 
Software, USA). Datasets were checked for normal distribution prior to analysis and 
subsequently compared using a student T-test. A p-value of ≤ 0.05 was considered 
significant. 
2.3. Results 
2.3.1. Detroit 562 monolayer development  
Most GAS biofilm studies utilise abiotic surfaces such as plastic, glass, or silicone, and 
very few incorporate host factors like ECM matrix components (collagen, laminin, 
fibronectin) as surface coatings. As such, these models poorly represent the human 
environment to which GAS naturally colonises. Here, Detroit 562 pharyngeal cell 
monolayers serve as the substratum for GAS biofilm growth.  
Detroit 562 pharyngeal cells were seeded at a concentration of 2x105 cells/mL on       
collagen I coated and uncoated surfaces of a 96-well plate. At 28 h of growth, the Detroit 
562 pharyngeal cells are most confluent on the collagen I coated wells (Fig 2.3A-C), 
whereas cells seeded on uncoated wells (Fig 2.3D-F) are of significantly lesser confluency 

















Figure 2.3. 28 h Detroit 562 monolayer development on collagen I coated (A-C) vs uncoated (D-F) 
well surface. Images taken at 10x objective at the Incucyte. Presented here are 3 biological replicates with 
1 representative technical replicate each. Each well was initially seeded with 2x105 Detroit 562 cells/mL.  
300 μm 
300 μm 300 μm 





The Detroit 562 pharyngeal cells were further incubated for a total growth period of 48 h 
with the aim of reaching monolayers of ≥ 95% confluency. It is important to have a highly 
confluent monolayer to ensure that subsequent GAS biofilms that form are consistent 
across the entirety of the biofilm, as opposed to biofilms for example having altered 
architecture/structure/arrangement in regions lacking Detroit 562 cell presence.   
It is evident by 48 h, Detroit 562 pharyngeal cells grown on the collagen I coated well 
surface reached the desired confluency (Fig 2.4A-C), covering the well surface 
thoroughly. However, Detroit 562 cells grown on uncoated well surface did not reach the 
desired confluency, with considerable gaps seen in the monolayer (Fig 2.4D-F).  
As such, collagen I coating is a necessary component in the formation of Detroit 562 
















Figure 2.4. 48 h Detroit 562 monolayer development on collagen I coated (A-C) vs uncoated (D-F) 
well surface. Images taken at 10x objective at the Incucyte. Presented here are 3 biological replicates with 
1 representative technical replicate each.  Each well was initially seeded with 2x105 Detroit 562 cells/mL.  
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Broth-grown GAS has been previously found to be inherently toxic towards live epithelial 
cells (Marks et al., 2014). Therefore, co-culturing GAS biofilms atop live epithelial cells 
for extended periods of time is not possible. Detroit 562 pharyngeal cell monolayers were 
fixed with 3.7% paraformaldehyde prior to use for biofilm production. To ascertain if this 
treatment induces any phenotypic or morphological changes or visible damage to the 
monolayers, the 48 h Detroit 562 pharyngeal cell monolayers were imaged pre- and post-
fixation (Fig 2.5). Fixation does not appear to induce any noticeable changes in the 
morphology of the pharyngeal cells, nor does it damage the monolayers and their 
confluency. To further exemplify this, 48 h monolayers grown on uncoated wells with a 












Figure 2.5. PFA fixation does not alter the morphology of Detroit 562 pharyngeal cells within the 
monolayers achieved at 48 h. Images show monolayers on collagen coated well surfaces pre-fixation (A) 
and post-fixation (B) and monolayers on uncoated well surfaces pre-fixation (C) and post-fixation (D). 
Images were taken at 10x objective at the Incucyte.  
2.3.2. GAS biofilm formation optimisation 
2.3.2.1. 48 h GAS biofilms are potentiated on Detroit 562 pharyngeal cell 
monolayers 
To exemplify and highlight the need for a more physiologically relevant substratum for 
GAS biofilm growth, two commonly studied GAS isolates, M1 and M12, implicated in 
GAS pharyngitis were assessed and were the primary focus of this study (Walker et al., 
2014). Specifically, 48 h M1 and M12 GAS biofilms were assessed for their biofilm 
forming abilities on both a plastic substratum and PFA fixed Detroit 562 pharyngeal cell 
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monolayers via crystal violet staining (Fig 2.6). Both GAS M-types were found to exhibit 


































Figure 2.6. M1 and M12 GAS was assessed for its ability to form biofilm on plastic and Detroit 562 
pharyngeal cell monolayers. Biofilms were formed for 48 h and biofilm biomass ascertained via crystal 
violet staining. Data represents mean ± SEM, ** (p ≤ 0.01) and **** (p ≤ 0.0001); n = 3 biological 
replicates, with 3 technical replicates each. 
2.3.2.2. Methanol fixation improves reproducibility of crystal violet staining 
on GAS biofilms 
Crystal violet assays were first described by Christensen et al. (1985) as a means of 
quantifying biofilm. Crystal violet has proven useful in that it detects biofilm in its 
entirety, staining a biofilms biomass which comprises live and dead cells, as well as EPS 
matrix. Taken together with its overall ease of use and relatively low cost it has since 
become a routinely used biofilm stain and detection method (Wilson et al., 2017). Despite 
these attributes, there are some drawbacks and limitations to crystal violet use, with 
concerns around reproducibility (Pantanella et al., 2013, Azeredo et al., 2017). 




during the wash steps (Azeredo et al., 2017). As such, more delicate biofilms may require 
additional precautions to ensure biofilm retention during the various washing, staining, 
and de-staining steps of the assay.  
In the current study, to minimise disruption and damage to the GAS biofilms, biofilm 
plate layout/growth conditions and overall handling were optimised according to the 
following specifications; growing biofilms at the inner-most wells of a plate with unused 
wells filled with water to avoid dehydration; adjusting pipetting volume for media 
removal to account for dehydration during incubations; placing the plate inside a 
container containing additional water to reduce media evaporation from the wells; gradual 
media changes (50 μL at a time, as opposed to the entire 150 μL). Furthermore, to improve 
the durability of the biofilms during crystal violet assaying, 48 h biofilms grown on the 
Detroit 562 pharyngeal monolayers were either fixed with methanol or left unfixed and 
assessed for biofilm biomass (Fig 2.7).   
Methanol fixation was found to significantly increase retention of biofilm biomass 
following crystal violet staining (Fig 2.7). Hence, for GAS biofilms, we recommend 





































Figure 2.7. Methanol fixation improves M1 and M12 GAS biofilm biomass detection. 48 h GAS 
biofilms were formed from planktonic GAS that had initially adhered to the monolayer after 2 h incubation. 
Biofilm biomass was ascertained via crystal violet staining. Data represents mean ± SEM, * (p ≤ 0.05) and 
** (p ≤ 0.01); n = 3 biological replicates, with 3 technical replicates each. 
2.3.2.3. 72 h growth yields optimal biofilm biomass 
After optimising the crystal violet assay for GAS biofilms, M1 and M12 GAS biofilm 
formation on the Detroit 562 pharyngeal cell monolayers was further assessed at extended 
growth periods of 72 and 96 h to see if greater biofilm biomass was achievable (Fig 2.8). 
Both M1 and M12 formed significantly more biofilm at 72 h compared to 96 h where 
biofilm biomass seemed to diminish. The biofilm biomass at 72 h was also greater than 
the biofilm biomass formed previously at 48 h.  
To build upon this and assess the utility of the optimised methodology, additional GAS 
M-types (M3, 98, and 108) were also assayed for biofilm formation under the same 
conditions (Fig 2.9). As per M1 and M12, both M98 and M108 formed significantly 
greater biofilm at 72 h compared 96 h. However, biofilm biomass remained relatively 



































                
 
Figure 2.8. 72 h is an optimal period for GAS biofilm formation. M1 and M12 were assessed for GAS 
biofilm formation at 72 and 96 h. 72 h yielded significantly more biofilm than 96 h. Biofilm biomass was 
determined via crystal violet staining. Data represents mean ± SEM, ** (p ≤ 0.01) and *** (p ≤ 0.001); n = 



































               
Figure 2.9. Assessing the utility of the optimised methodology on additional GAS M-types (M3, 98, 
and 108). Biofilm biomass was determined via crystal violet staining. Data represents mean ± SEM, ** (p 




2.3.3. SEM imaging reveals 72h M1 and M12 GAS biofilms formed in the host cell-
GAS model closely resemble those in vivo 
M1 and M12 72 h biofilms grown on Detroit 562 pharyngeal cell monolayers were 
visually observed by SEM for their overall biofilm architecture, arrangement, and 
structure. Both M1 and M12 GAS biofilms show cocci chains arranged in three-
dimensional aggregated communities atop the Detroit 562 pharyngeal cell monolayers 
(Fig 2.10). However, M1 biofilms were found to arrange in tightly packed aggregates of 
cocci chains on the Detroit 562 monolayers (Fig 2.10 A and B), whereas M12 biofilms 
were more loosely arranged atop of the monolayers (Fig 2.10 C and D). Both M1 and 
M12 biofilms produced noticeable EPS that was found closely associated with the cocci 
chains. Detroit 562 pharyngeal cell monolayers (without biofilm) are also shown (Fig 2. 
10 E and F) depicting the pharyngeal cells arranged in confluent monolayers, with 
















Figure 2.10 Representative 72 h M1 (A and B) and M12 (C and D) GAS biofilms visualised by 
scanning electron microscopy at 500 and 15 000 x magnification. GAS biofilms show chained cocci 
(white arrows) arranged into three dimensional aggregated structures with EPS (black arrows) upon the 
Detroit 562 monolayers (smaller white arrows). Detroit 562 monolayers (without biofilm) were also imaged 





GAS is a human pathogen, reliant on several host factors to prompt and facilitate dynamic 
and unique interactions necessary for successful colonisation and persistence. Most in 
vitro plate-based GAS biofilm models used previously do not mimic the host 
environment. Moreover, the use of an epithelial substratum for growth is rare. Given the 
importance of the GAS-host tissue interface in mediating the earlier stages of GAS 
association and adherence, it is likely that these interactions are also crucial for various 
stages of subsequent biofilm formation and establishment within the host. Thus, 
modelling in the absence of host factors and/or relevant host epithelial substratum in in 
vitro plate-based biofilm models may result in biofilms that do not accurately represent 
the GAS biofilms in vivo. Here we report an optimised method for GAS biofilm formation 
using Detroit 562 pharyngeal cell monolayers as a model for GAS-host interaction. 
In the current study, an optimised method for culturing GAS biofilms on pharyngeal cell 
monolayers was developed. Despite not being a primary cell line, Detroit 562 pharyngeal 
cells were considered suitable for this model for the following reasons; i) they are derived 
directly from human pharyngeal tissue, a site which GAS readily colonises, ii) they retain 
surface structures for adherence (e.g. carbohydrate epitopes) representative of native 
pharyngeal cells, and iii) they have been used extensively in planktonic GAS adherence 
assays (Barthelson et al., 1998, Ryan et al., 2001, Frick et al., 2003, Bessen and Lizano, 
2010, Ryan and Juncosa, 2016). Future research may wish to adapt this model further, 
considering the use of other relevant cell types, such as alternative pharyngeal cell lines, 
primary oropharyngeal tissue and keratinocyte cell lines, as substratum for biofilm 
formation. Overall, utilisation of pharyngeal epithelial substratum within this model 





When grown on Detroit 562 pharyngeal cell monolayers, GAS biofilm biomass increased 
significantly compared to biofilms grown on abiotic plastic substratum. This highlights 
the difference in biofilm potentiation, as a direct result of substratum for biofilm growth. 
This supports the utility for GAS biofilm modelling to include epithelia as a substratum 
for biofilm growth over an abiotic plastic surface.  
Whilst various staining techniques have been developed to assess biofilm biomass, crystal 
violet staining remains one of the most common techniques within the field. Here, we 
propose optimisation of this method at the biofilm formation steps preceding crystal violet 
staining, as well as additional considerations required during the crystal violet assay that 
are tailored to the GAS biofilms formed using this model. Specifically, to further improve 
biofilm yield, durability, and subsequent reproducibility of the commonly used biofilm 
biomass crystal stain assay, methanol fixation was assessed. 48 h GAS biofilms that were 
methanol fixed prior to crystal violet staining yielded greater biofilm biomass, with less 
biofilm loss during the intensive staining and washing steps. In turn, reducing error, and 
increasing reproducibility. 
Broth grown GAS is inherently toxic to epithelial cells, as such, there have previously 
been no models that explore or support long-term GAS biofilm-epithelia co-culture in a 
plate-based model (Marks et al., 2014). Here, we show that GAS biofilm formation is 
attainable upon the fixed pharyngeal cell monolayer beyond 48 h. However, of the three 
time points assessed, 72 h is the optimal biofilm growth period for yielding the greatest 
biofilm biomass for M1, M12, M98, and M108 GAS. Biofilm biomass was seen to 
diminish at 96 h, likely resulting from partial disintegration of biofilm. This may be 
indicative of a mature or older biofilm reaching the final step of the biofilm life cycle - 
dispersal. Dispersal is thought to be triggered by nutrient exhaustion at the site, which in 
a host enables bacteria to shift to a motile planktonic state for biofilm re-establishment 




results conferred with a previous study of M6 and M49 biofilms grown on abiotic plastic 
well surfaces of a 96 well plate-based system, whereby biofilms had greater biomass at 
72 h, and exhibited partial disintegration at 96 h with authors attributing this to the age of 
the biofilm and nutrient limitation (Lembke et al., 2006). 
Finally, visual inspection of the GAS biofilms via SEM imaging found M1 and M12 
formed biofilm atop the Detroit 562 pharyngeal cell monolayers. Cocci chains, typical of 
GAS, can be seen arranged in three dimensional aggregated structures coated in EPS 
matrix for both GAS M-types. Importantly, biofilms formed in this GAS-epithelial cell 
model appear similar to SEM images captured of GAS biofilms found at the surface of 
tonsils removed from patients with recurrent GAS tonsillo-pharyngitis (Roberts et al., 
2012). In conclusion, we have demonstrated an efficacious GAS biofilm-pharyngeal cell 
model that can support long-term biofilm formation, with biofilms formed resembling 





Chapter 3: Assessing the role pharyngeal cell surface glycans 
play in throat tropic M12 GAS biofilm formation 
A part of this work has been published in Antibiotics, MDPI.   
Overview: The role host cell glycans play in GAS biofilm formation in the context of 
GAS pharyngitis and subsequent antibiotic treatment failure has not been previously 
investigated. GAS serotype M12 GAS biofilms were assessed for biofilm formation on 
Detroit 562 pharyngeal cell monolayers following enzymatic removal of all N-linked 
glycans from pharyngeal cells with PNGase F. Removal of N-linked glycans resulted in 
an increase in biofilm biomass compared to untreated controls. Further investigation into 
the removal of terminal mannose and sialic acid residues with α1-6 mannosidase and the 
broad specificity sialidase (Sialidase A) also found that biofilm biomass increased 
significantly when compared to untreated controls. Increases in biofilm biomass were 
associated with increased production of extracellular polymeric substances (EPS). 
Furthermore, it was found that M12 GAS biofilms grown on untreated pharyngeal 
monolayers exhibited a 2500-fold increase in penicillin tolerance compared to planktonic 
GAS. Pre-treatment of monolayers with exoglycosidases resulted in a further doubling of 
penicillin tolerance in resultant biofilms. Collectively, these data demonstrate that 
pharyngeal cell surface glycan structures directly impact GAS biofilm formation in a 





GAS pharyngitis is the most common disease state, with global incidence estimated at 
600 million cases per year (Carapetis et al., 2005). Currently, penicillin remains the 
antibiotic of choice for treating GAS infections, with no reports of penicillin resistance 
among clinical GAS isolates. However, antibiotic treatment failure has been well-
documented at rates of 20–40% for GAS pharyngitis (Facinelli et al., 2001, Conley et al., 
2003, Baldassarri et al., 2006). Biofilms enable bacteria to survive and tolerate both host 
immunity and antimicrobial treatment. As a result, biofilm-associated infections are 
oftentimes chronic and recurrent, and particularly difficult to clear and treat (Conley et 
al., 2003, Baldassarri et al., 2006, Ogawa et al., 2011). Recently, it has been proposed that 
GAS may form biofilms, contributing to antibiotic treatment failure (Conley et al., 2003). 
There is evidence of bacterial biofilm formation in human tonsils (Kania et al., 2007), and 
in a study of patients suffering from recurrent GAS pharyngo-tonsillitis, the presence of 
GAS biofilms in tonsillar crypts was identified in all 30 patients (Roberts et al., 2012). 
Furthermore, in a study assessing GAS isolated from pharyngitis patients non-responsive 
to antibiotics, all 99 GAS isolates demonstrated biofilm-forming ability in vitro, with 
60% of these displaying increased penicillin tolerance once in the biofilm phenotype 
(Conley et al., 2003). However, most of these studies utilised abiotic surfaces (glass, 
plastic, polystyrene) and very few incorporated surface coating with extracellular matrix 
components such as fibronectin, fibrinogen, laminin, or collagen (Lembke et al., 2006, 
Manetti et al., 2007, Sugareva et al., 2010, Bachert et al., 2016). The host cell surface is 
integral in initial host-pathogen interactions, bacterial cell adherence, and subsequent 
biofilm formation (Kostakioti et al., 2013). Thus, there is a need to better understand the 
role of host cell surface receptors in GAS biofilm formation. 
Glycans are carbohydrates present on more than half of all human proteins, with their 




of epithelial cell surfaces, making glycosylation one of the most common post-
translational modifications (Apweiler et al., 1999, Christiansen et al., 2014). Glycans are 
the initial point of contact with the host for many bacteria, mediating attachment and 
colonisation, and can consequently facilitate infection and disease. Several human 
bacterial pathogens such as Pseudomonas aeruginosa, Enterococcus faecalis, 
Helicobacter pylori, Streptococcus gordonii, and Streptococcus pneumoniae have proven 
adept at adhering to and utilising glycan structures for pathogenesis (Aspholm et al., 2006, 
King, 2010, Garbe et al., 2014, Wong et al., 2018, Wheeler et al., 2019). Bacterial 
modification of host glycan structures enables binding to otherwise inaccessible host 
receptors for adherence, modulation of host immune molecules, acquisition of 
carbohydrate substrates for non-glucose fermentation, facilitation of interspecies 
competition, and promotion of biofilm formation (Aspholm et al., 2006, King, 2010, 
Garbe et al., 2014, Wong et al., 2018, Wheeler et al., 2019). An example of a well-
characterised glycan-utilising system is the NanA neuraminidase of S. pneumoniae, 
which cleaves off terminal sialic acid residues from glycans. NanA has been shown to be 
particularly active during cluster formation and biofilm maturation in vitro (Parker et al., 
2009). Another study found increased S. pneumoniae biofilm formation was seen only 
for biofilms exposed to sialic acid, but not in the presence of other glycans (Trappetti et 
al., 2009). 
The utilisation of glycans by GAS remains poorly understood, despite GAS possessing 
an array of adhesins capable of binding structures on the richly glycosylated epithelial 
surfaces and in the fluids of the oropharynx. Studies to date have focused on planktonic 
GAS-host glycan interactions in the context of the M protein, a major surface-expressed 
protein which has a role in the adherence of GAS to host tissues (Wang and Stinson, 1994, 
Frick et al., 2003, De Oliveira et al., 2017, De Oliveira et al., 2019). Investigation of the 




dermal-associated glycosaminoglycans (GAGs) revealed that GAGs mediated GAS 
adhesion to human cells in an M protein-dependent manner (Frick et al., 2003). Recently, 
M1 GAS was shown to bind glycans via the M protein, including the ABO(H) blood 
group antigens, which are oligosaccharides abundant on the epithelia of most individuals, 
including the pharynx (De Oliveira et al., 2017). Similar trends were observed in two 
other prevalent GAS M-types, M3 and M12 (De Oliveira et al., 2019). Interestingly, this 
study showed that modification of the cell surface glycome via treatment with a range of 
exoglycosidases altered GAS-host cell interactions (De Oliveira et al., 2019). Taken 
together, these findings further highlight the role of glycans in mediating GAS adherence. 
Whilst the role of host glycans in GAS adherence has been investigated, their role in GAS 
biofilm formation has yet to be examined. Investigation of glyco-interactions at the GAS-
tissue interface in the context of biofilms will enhance our understanding of GAS biofilms 
and GAS pathogenesis. Consequently, findings of such studies may inform and support 
the development of novel anti-biofilm strategies as well as biofilm-specific antibiotic 
treatments. Herein, we examine the role of human pharyngeal N-glycans in M12 GAS 
biofilm formation and subsequent penicillin tolerance. 
3.2. Materials and methods 
3.2.1. GAS and culture conditions 
M12 GAS used in this study is commonly associated with pharyngeal disease (Sanderson-
Smith et al., 2014, De Oliveira et al., 2017, De Oliveira et al., 2019). GAS was grown on 
horse blood agar (HBA) plates (Oxoid, UK) or Todd Hewitt agar supplemented with 1% 
(w/v) yeast (THYA) (Difco, Australia). Static cultures of GAS were grown overnight in 
Todd Hewitt broth supplemented with 1% (w/v) yeast (THY). GAS was cultured and 




3.2.2. Human pharyngeal cell culture conditions and monolayer formation 
Detroit 562, a human pharyngeal epithelial cell line (CellBank Australia, Australia), was 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) F12 (Invitrogen, Australia), 
supplemented with 2 mM L-glutamine (Gibco, Life Technologies, UK) and 10% (v/v) 
heat inactivated foetal bovine serum (FBS) (Bovogen Biologicals, Australia) in cell 
culture flasks at 37 °C, 5% CO2 to 20% O2 atmosphere. 
Fixed Detroit 562 pharyngeal cell monolayers form the substratum for bacterial growth 
for subsequent biofilm experiments. In brief, wells of 96-well flat bottom cell culture 
microtiter plates (Greiner Bio-One, Germany) were coated with 300 µg/mL Collagen I 
from rat tail (Gibco, Life Technologies, UK) and incubated for 1 h, 37 °C, 5% CO2 to 
20% O2 atmosphere. After 1 h, wells were seeded with 150 µL Detroit 562 cell suspension 
(2 × 105 cells/mL) and cultured for 48 h (or until a monolayer of ~95% confluency was 
achieved). Monolayers were washed once with PBS and fixed with sterile 3.7% 
paraformaldehyde for 20 min. Once fixed, wells were washed twice with PBS, and 
monolayers were kept wet via submersion in PBS until required for use. 
3.2.3. Characterisation of Detroit 562 pharyngeal cell surface N-linked glycans 
Characterisation of the Detroit 562 pharyngeal cell surface N-linked glycans purified from 
cell surface glycoproteins was conducted as per the methods developed by Everest-Dass et 
al. (2012) with slight modification. In brief, 3 different passages derived from the same vial 
of the Detroit 562 cells (representative of 3 biological replicates) were pelleted and washed 
once in 14 mL PBS by centrifugation (20 min, 1000g, 4℃) in a Heraeus Multifuge X3R 
centrifuge (Thermofisher Scientific, USA). Cells were counted using a haemocytometer 
and cell concentration adjusted to 2x108 cells/mL and pelleted by centrifugation (5 min, 
1000g, 4℃). The pellet was re-suspended in 2 mL of lysis buffer and thoroughly 
homogenised using a Branson 250 digital sonicator (Branson, USA) (30% amplitude, 6 




containing the cellular proteins was collected from the centrifuged homogenate and further 
diluted with lysis buffer and sedimented by ultracentrifugation (1 h, 100 000g, 4℃) with a 
Sorvall MTX 150 Micro-Ultracentrifuge (Thermofisher Scientific, USA) (Ryan et al., 
2001). Resultant membrane protein pellet was re-suspended in 1 mL lysis buffer containing 
1% Triton X-114 (v/v), and the pellet completely homogenised. Samples were heated at 
37℃ for 20 min, and phase partitioned by centrifugation (5 min, 300 g, RT). The Triton X-
114 layer containing the membrane proteins were precipitated with 9 volumes of ice-cold 
acetone and incubated overnight at -20℃. The precipitated membrane proteins were re-
solubilised in 100 µL of 8 M urea, and protein quantified by DC assay. 20 µg of protein 
lysate from each of the 3 passages were independently dot blotted in triplicate onto EtOH-
wetted PVDF membrane (20 µg of BSA and bovine fetuin were included as glycan negative 
and positive controls respectively) and dried overnight (RT). Dried dot blots were then 
washed in MeOH (15 min, shaking, RT) and further washed in water (15 min, shaking, 
RT). To qualitatively confirm and visualise immobilised protein, the dot blotted membrane 
was stained with Coomassie blue for 3 min, and then de-stained, and the membrane placed 
in water. Protein-laden spots of 6mm diameter were excised from the PVDF membrane and 
submerged into wells containing 100 µL 1% PVP40 where they were incubated for 5 min, 
and then washed three times with 200 µL water. For the removal of N-linked glycans, 2 µL 
of PNGase F (1000 U) (NEB) and 8 µL water was added to each well and incubated 
overnight at 37℃. After incubating overnight, the 96-well plate was sonicated for 5 min in 
an Ultrasonic Cleaner sonicating water bath (Unisonics, Australia). The wells were then 
rinsed with 20 µL water, and the solutions collected. The samples were then acidified with 
10 µL 100 mM ammonium acetate (pH 5) and incubated for 1 h, RT. Released N-glycans 
were reduced in alkaline conditions by the addition of 20 µL of 1.25 M NaBH4 in 100 mM 
KOH, incubated for 3 h at 50℃. After cooling to RT, the reaction was neutralised with 2 




Sodium salts of N-glycan solutions were removed by passage through and subsequent 
washing of cation exchange microcolumns constituted by packing 25 µL of Dowex® 50W 
X8 (Sigma-Aldrich, USA) in a ZipTip® C18 tip (Merck Millipore), activated with 50 µL 
of 1 M HCl prior to addition of sample. Solutions were passed through columns using a 
benchtop micro-centrifuge at full speed for 15-30 s. Sodium-desalted samples were vacuum 
dried in a Savant  SPD131DDA SpeedVac™ Concentrator (ThermoFisher). Samples were 
then washed and dried three times with 100 µL of methanol to remove residual borate. 
Desalted samples were further purified by porous graphitised carbon (PGC) 
chromatography. Columns were constituted with 5 µL of PGC material from HyperSep  
Hypercarb  cartridges (ThermoFisher) in methanol, deposited in a ZipTip® C18 tip. Prior 
to addition of sample, columns were washed with elution buffer (80% v/v acetonitrile 
(ACN), 0.1% v/v trifluoroacetic acid (TFA)) and subsequently equilibrated in loading 
buffer (0.1% v/v TFA). Dried samples were dissolved in 50 µL loading buffer and passed 
through columns, with flow through re-loaded into the columns. Enriched glycans were 
eluted in 50 µL of elution buffer and vacuum dried. Dried, purified enriched glycans were 
stored at –20 ℃. 
Dried glycans were reconstituted in 20 µL of water immediately prior to LC-MS/MS 
analysis. Sample handling and injections were performed using an Ultimate 3000 UHPLC 
(Thermo Scientific). Samples were injected in running buffer (10 mM NH4HCO3) through 
a PGC pre-column (3 µm Hypercarb, 320 µm ID x 100 mm) at a flow rate of 6 µL/min and 
subsequently a PGC analytical column (3 µm Hypercarb, 75 µm ID x 100 mm) at a flow 
rate of 1 µL/min. Chromatographic separation was achieved using a 120 min gradient for 
N-glycans (0 – 70% v/v ACN). The HPLC system was directly connected to an electrospray 
ionisation source (AmaZon Speed Ion-Trap, Bruker Corporation, UK) with a capillary 
voltage of 3 kV. MS spectra were obtained in negative mode between m/z 400 and 1800 




Data analyses were carried out in Compass Data Analysis 4.2 (Bruker Corporation) for 
structural assignment and in Skyline 20.1 (MacLean et al., 2010) for quantitation. 
Quantitation was performed for each isomer identified by MS2 spectra and retention time 
by calculating the area under the curve (AUC). This was expressed as a percentage of total 
AUC yielding relative abundance for each replicate. 
3.2.4. Detroit 562 pharyngeal cell monolayer pre-treatment 
3.2.4.1. PNGase F treated monolayers 
Wells of the 96-well microtiter plates containing pre-formed fixed Detroit 562 pharyngeal 
cell monolayers were blocked with 1% PVP40 solution and incubated for 5 min. Once 
blocked, the PVP40 was removed, and the wells washed three times with distilled water. 
For the removal of N-linked glycans, 5 µL of PNGase F (50 U) (Promega, Madison, WI, 
USA) and 10 µL PBS was added to each well and incubated overnight at 37 °C. After 
incubating with PNGase F, released N-linked glycans were removed and the wells washed 
once with PBS. Untreated PBS wells representing the whole glycome of the Detroit 562 
pharyngeal cell monolayers were also included as a control. N-linked glycan removal was 
confirmed via Concanavalin A Alexa fluor 647 lectin binding assay (Appendix D, Figure 
D). In brief, untreated and PNGase F pre-treated pharyngeal cell monolayers were 
incubated with 5 µg/mL Concanavalin A Alexa fluor 647 for 15 min (RT, dark). Unbound 
lectin removed, and monolayers washed twice with 100 µL PBS. Untreated and PNGase 
F pre-treated monolayers incubated without lectin (PBS) served as background/auto-
fluorescence controls and were subtracted from sample reads. Samples were read 




3.2.4.2. Exoglycosidase: α1-6 mannosidase, α1-2, 3 mannosidase, and 
Sialidase A treated monolayers 
Pre-formed fixed Detroit 562 pharyngeal cell monolayers of the 96-well microtiter plate 
were treated with 30 µL/well reaction volumes of each of the exoglycosidases. For 
mannosidases, the reaction volume comprises 3 µL 1 × GlycoBuffer 1 (NEB), 0.3 µL 100 
µg/mL purified BSA (NEB), 0.2 µL α1-6 mannosidase (8 U) or α1-2,3 mannosidase (8 
U) (NEB), and 26.5 µL PBS. For Sialidase A, 6 µL 5 × Reaction Buffer B (250 mM 
sodium phosphate pH 6.0) (Prozyme, Hayward, CA, USA), 0.2 µL Sialidase A                    
(1 × 10–3 U) (Prozyme, Hayward, CA, USA), and 23.8 µL PBS. Untreated PBS wells 
representing the intact surface glycome of the fixed Detroit 562 pharyngeal cell 
monolayers were also included as a control. The plate was incubated for 2 h, 37 °C. Once 
incubated, the wells were washed once with PBS. Glycan removal was confirmed via 
lectin binding assay as per (De Oliveira et al., 2019), with exoglycosidase pre-treated 
pharyngeal cell monolayers incubated with either biotinylated Hippeastrum hybrid lectin 
(binding mannose residues) (Vector Laboratories, Australia) or biotinylated Sambucus 
nigra lectin (binding sialic acid residues) (Vector Laboratories, Australia) (Appendix E, 
Figure E). 
3.2.5. Initial adherence of planktonic GAS 
Pre-formed fixed Detroit 562 pharyngeal cell monolayers were inoculated with 150 µL 
of stationary phase GAS culture diluted 1:20 in THY (v/v) supplemented with sterile 0.5% 
glucose (THY-G) and incubated for 2 h to promote initial attachment (34 °C, slow 
shaking at 50 rpm). At 2 h, non-adherent GAS was removed, and the wells washed three 
times with PBS. To detach Detroit 562 cells from the bottom of the microtiter plate, 
0.05% trypsin-EDTA (1×) (Gibco, USA) was added to each well and incubated (15 min, 
37 °C). To lyse the now-detached Detroit 562 cells containing internalised bacteria, 




GAS population, 10-fold serial dilutions of the cell suspensions were performed in PBS 
and aliquots spot plated onto THYA (incubated overnight, 34 °C) for subsequent colony 
counting and CFU/mL determination. 
3.2.6. GAS biofilms 
96-well microtiter plates containing pre-formed fixed Detroit 562 pharyngeal cell 
monolayers untreated and pre-treated with either PNGase F or the exoglycosidases were 
inoculated with 150 µL of overnight GAS culture diluted 1:20 in THY-G. The inoculum 
was incubated for 2 h (34 °C, 50 rpm). At 2 h, non-adherent GAS was removed, and wells 
replenished with sterile THY-G. Subsequent 72 h GAS biofilms were produced (34 °C, 
50 rpm), with sterile THY-G media refreshment performed every 24 h. 
3.2.6.1. GAS biofilm biomass crystal violet staining 
Biofilm biomass was assessed via crystal violet staining. Biofilms were air dried for 30 
min (or until completely dried), and fixed with 99% methanol for 15 min. Once fixed, the 
biofilms were thoroughly air-dried and stained with 0.2% crystal violet (w/v) (Sigma-
Aldrich, St Louis, MO, USA) supplemented with 1.9% ethanol (v/v) for 10 min (RT, 
static). Once stained, excess crystal violet was removed and each well gently washed 
twice with PBS. Crystal violet stain that had incorporated into the biofilm was re-
solubilised in 1% sodium dodecyl sulphate (SDS) (w/v) (Sigma-Aldrich, St Louis, MO, 
USA), and incubated (10 min, RT). Monolayers with THY-G (no GAS biofilm) served 
as media sterility controls and background staining controls, with absorbance values 
subtracted from those of biofilm samples. Biofilm biomass quantification was performed 
by diluting the released dye 1:5 in the 1% SDS solution, and subsequently measured at 




3.2.6.2. GAS biofilm cell viability 
GAS biofilms were assessed for viability via i) live cell populations determined via 
enumeration of serially diluted biofilms and ii) live/dead staining with Syto9/PI. 
3.2.6.2.1. Enumeration of live cells within GAS biofilms 
GAS biofilms were assessed for the live cell populations via enumeration of serially 
diluted biofilms. Briefly, biofilms were washed once in PBS and thoroughly re-suspended 
in fresh PBS via vigorous scraping of biofilms from the well surface, followed by a 5 min 
sonication. The population of live cells within these biofilms were enumerated via 10-fold 
serially diluting in PBS, and spot plating onto THYA (incubated overnight, 34 °C) for 
subsequent colony counting and CFU/mL determination. 
3.2.6.2.2. Determining percentage live/dead within the GAS biofilms 
Biofilms were washed once in PBS and thoroughly re-suspended in fresh PBS. Viable 
cells were enumerated via 10-fold serially diluting in PBS, and spot plating aliquots of the 
dilutions onto THYA (incubated overnight, 34°C) for subsequent colony counting and 
CFU/mL determination. Live/dead staining with Syto9/PI was based off Bac Light bacterial 
viability staining kit L7012 (Invitrogen, Molecular Probes, USA) manufacturer's 
instructions with some modifications. In brief, biofilms were washed once with 0.9% NaCl 
buffer (w/v) and stained with Syto9/PI combined (3µM and 18µM respectively) for 15 min 
in the dark. Controls were also included (0.9% NaCl buffer, Syto9 alone, and PI alone). 
Fluorescence was measured in a CLARIOstar (BMG Labtech, Germany) microtiter plate 
reader at 485-15 nm excitation, and emissions of 530-20 nm and 630-20 nm collected for 
Syto9 and PI respectively. Results are expressed as percentages of live/dead populations 
by:  
1)  % 𝐷𝑒𝑎𝑑 =  
𝑉𝑎𝑙𝑢𝑒 𝑜𝑓 𝑃𝐼
𝑉𝑎𝑙𝑢𝑒 𝑜𝑓 𝑆𝑦𝑡𝑜9
 × 100 % 




3.2.6.3. GAS biofilm EPS 
To assess a biofilms EPS, the i) EPS-GAGs and ii) common EPS components (eDNA 
and protein) were examined. Briefly, EPS associated GAGs were quantified by 1,9-
dimethyl methylene blue (DMMB) dye based EPS assay adapted from methods described 
elsewhere (Peeters et al., 2008). EPS components (eDNA and protein) were fluorescently 
stained with Sytox Blue, a cell membrane-impermeant nucleic acid stain (Molecular 
Probes, Invitrogen, Eugene, OR, USA) and FilmTracer SYPRO Ruby biofilm matrix 
stain that labels most classes of proteins (Molecular Probes, Invitrogen, Eugene, OR, 
USA). In brief, biofilms were fixed with 99% methanol for 15 min, and subsequently air 
dried. Biofilms were individually stained for 30 min in the dark with 5 µM Sytox Blue 
and 0.5× concentration FilmTracer SYPRO Ruby biofilm matrix stain, with PBS as a 
control. Fixed Detroit 562 pharyngeal monolayers without biofilm were also stained and 
served as controls for background staining, with resultant absorbance values subtracted 
from biofilm EPS measurements. Fluorescence was measured using a CLARIOStar (with 
6 × 6 matrix well scanning of the non-homogenous biofilms). Sytox Blue was read with 
an excitation of 440–15 nm and emission of 484–20 nm, and FilmTracer SYPRO Ruby 
biofilm matrix read with an excitation of 450–15 nm and emission of 610–20 nm. 
3.2.7. M12 GAS penicillin susceptibility 
As per accepted guidelines and standard protocols the MIC and MBC values were 
determined for penicillin activity against planktonic M12 GAS (Oliva and Chopra, 1992, 
Pankey and Sabath, 2004). Briefly, M12 planktonic GAS suspension (1 × 106 CFU/mL) 
was challenged with serially diluted penicillin and incubated (24 h, 34 °C). The MIC was 
defined as the lowest concentration of penicillin required to completely inhibit bacterial 
growth (indicated by clear wells), and further confirmed by measuring OD600nm using a 
SpectraMax Plus 384 microplate reader (See Appendix F, Figure F). MBC was defined 




as determined upon spot plating on THYA. For biofilm susceptibility, MBEC was 
determined by challenging the pre-formed biofilms with 2-fold dilutions of penicillin in 
THY, 2% G (v/v) (24 h, 34 °C). Biofilms were washed once in PBS and thoroughly re-
suspended in fresh PBS. Viable cells were enumerated via 10-fold serially diluting in 
PBS, and spot plating onto THYA (incubated overnight, 34 °C) for subsequent colony 
counting and CFU/mL determination. The MBEC was determined as the lowest 
concentration of penicillin required to induce complete eradication of the GAS biofilms 
(Ceri et al., 1999). 
3.2.8. Scanning electron microscopy 
M12 GAS biofilms were grown on untreated and PNGase F or exoglycosidase pre-treated 
fixed Detroit 562 pharyngeal monolayers on 13 mm plastic Nunc Thermanox coverslips 
(Proscitech, Rochester, NY, USA) in a 12-well polystyrene plate. Biofilms were air dried, 
and prepared for SEM using methods adapted from (Williams and Bloebaum, 2010) with 
the following modifications. In brief, biofilms were pre-fixed in 2.5% glutaraldehyde,     
50 mM L-lysine monohydrochloride, and 0.001% ruthenium red solution prepared in 0.1 
M HEPES buffer (pH 7.3) (30 min, 4 °C). Following pre-fixation, biofilms were fixed in 
fixative solution (2.5% glutaraldehyde and 0.001% ruthenium red prepared in 0.1 M 
HEPES buffer, pH 7.3) for 1.5 h (4 °C) and washed twice in 0.1 M HEPES buffer. Post-
fixation (2 h), 2% osmium tetroxide vapour was used, followed by three washes with 
distilled water (each 15 min). A graded ethanol series (30%, 50%, 70%, 90%, and 3 × 
100%) was then used to remove all water from the biofilms before they were critical point 
dried (Leica CPD 030, Austria). Dried biofilms were then sputter coated with 20 nm 
platinum (Edwards Vacuum coater, USA) and visualised using a JEOL JSM-7500 
microscope (JEOL, Japan) at 15 000x magnification. Untreated and PNGase F or 
exoglycosidase pre-treated fixed Detroit 562 pharyngeal monolayer controls (without 




within the samples by an UOW Electron Microscopy Centre technician blinded from the 
study in an effort to reduce bias. 
3.2.9. Statistical analysis 
All statistical analysis was performed using GraphPad Prism (version 8.4.0, GraphPad 
Software, USA). A student’s t-test or a one-way ANOVA was performed with a Tukey’s 
multiple comparisons post hoc test where relevant. A p-value of ≤ 0.05 was considered 
significant. 
3.3.  Results 
3.3.1. Indiscriminate removal of N-linked glycans from the pharyngeal cell surface 
via PNGase F treatment results in increased M12 GAS biofilm biomass 
M12 GAS, an M-type frequently associated with GAS pharyngitis (Cunningham, 2000, 
Walker et al., 2014), was investigated for its biofilm-forming ability on PFA fixed Detroit 
562 pharyngeal monolayers following removal of N-linked glycans via                                         
peptide-N-glycosidase F (PNGase F) treatment. Initial adherence of planktonic M12 GAS 
was determined by colony forming units, and biofilms were assessed for biofilm biomass 
and live bacterial cell count by crystal violet staining and colony forming units 
determination, respectively (Fig 3.1A). In the absence of N-linked glycans, planktonic 
M12 GAS displayed a significant decrease in initial adherence (p ≤ 0.05) when compared 
to adherence to untreated cells (Fig 3.1B). Despite a reduction in initial GAS adherence, 
M12 GAS biofilm biomass increased significantly (p ≤ 0.0001) on the surface of PNGase 
F treated cells compared to the untreated control (Fig 3.1C). However, PNGase F pre-
treatment of monolayers did not significantly affect the GAS CFU within the biofilms 












Figure 3.1. Indiscriminate removal of N-linked glycans from the pharyngeal cell surface via PNGase 
F treatment results in increased M12 Group A Streptococcus (GAS) biofilm biomass. (A) Assay 
schematic for 72 h M12 GAS biofilms formed on PNGase F pre-treated and untreated pharyngeal 
monolayers. (B) Initial adherence enumerated for planktonic GAS following 2 h incubation with Detroit-
562 cell monolayers. 72 h biofilms were assessed for (C) biofilm biomass via crystal violet staining and 
(D) colony forming units via enumeration. Data represents mean ± SEM, with statistical analysis performed, 













































































































To visually investigate the effect of PNGase F pre-treated pharyngeal monolayers on M12 
GAS biofilm formation, SEM imaging was conducted. Biofilms formed on both untreated 
and PNGase F pre-treated monolayers show M12 GAS chained cocci arranged into three 
dimensional aggregated structures with extracellular polymeric substances (EPS) matrix 
material present (Fig 3.2). Biofilms formed on PNGase F pre-treated pharyngeal 
monolayers (Fig 3.2C) appear to have more EPS matrix compared to biofilms formed on 
untreated cells (Fig 3.2A). EPS matrix material is associated with the aggregated GAS 
cocci. Interestingly, the EPS produced on the GAS biofilms seemed to come in two 
distinct forms, a web-like mesh matrix (small black arrows) and a more globular matrix 
(large black arrows). 
Untreated and PNGase F pre-treated Detroit 562 pharyngeal monolayers (without 
biofilm) were also imaged as controls to ensure that PNGase F treatment did not affect 












Figure 3.2. Visual inspection of 72 h M12 GAS biofilms captured via SEM revealed substantial 
extracellular polymeric substances (EPS) present in biofilms formed on PNGase F pre-treated 
pharyngeal cell monolayers. Images are representative of biofilms formed on (A) untreated and (C) 
PNGase F pre-treated pharyngeal monolayers. GAS biofilms show chained cocci (white arrows) arranged 
into three dimensional aggregated structures with EPS matrix material present (big and small black arrows). 
SEM images of (B) untreated and (D) PNGase F pre-treated Detroit 562 pharyngeal cell monolayers 
(without biofilm) are also included. Biofilms and Detroit 562 pharyngeal cell monolayers (without biofilm) 
were imaged using the JEOL JSM-7500 microscope at 15 000× and 500× magnification, respectively. SEM 
images were randomly selected and represent two biological replicates with two technical replicates each. 
3.3.2. Characterisation of N-linked glycans from Detroit 562 Pharyngeal cell 
surface reveals abundance of mannose and sialic acid terminating glycan structures 
To further examine the role of host N-glycans on the surface of pharyngeal monolayers 
in GAS biofilm formation, a comprehensive profile of the Detroit 562 pharyngeal cell 
surface N-glycome was determined. Membrane proteins were purified from pharyngeal 
cell culture lysates and treated with PNGase F. Released N-glycans were identified using 
porous graphitised carbon liquid chromatography (PGC-LC) and tandem mass 
spectrometry by electrospray ionisation (ESI-MS/MS). A total of 19 unique structures 




Quantitation by relative abundance revealed oligomannose structures to be the 
predominant class of N-glycans, comprising 82.03% of the Detroit 562 pharyngeal cell 
surface N-glycome (Fig 3.3A) with further analyses confirming that mannose was by far 
the most abundant terminal monosaccharide, followed by sialic acid and galactose (Fig 
3.3B). Terminal N-acetylglucosamine was detected at a very low abundance (<0.01%). 
Core fucosylation was observed in 14% of structures. Glycans were identified based 
primarily on MS2 fragmentation data with representative spectra of the most abundant N-





Figure 3.3. Structures bearing terminal mannose predominate the surface of Detroit 562 pharyngeal 
cells as determined by PGC-LC-ESI-MS/MS. (A) Surface N-glycans are primarily oligomannose 
structures. (B) Mannose is the most abundant terminal monosaccharide of N-glycans. (C) Examples of 
oligomannose, complex, and hybrid N-glycans are provided, including relative abundance and mass-to-
charge ratio (m/z) as detected by MS. Structures were identified primarily using MS2 spectra (D–F) (Ceroni 
et al., 2008, Harvey et al., 2008, Everest-Dass et al., 2012, Everest-Dass et al., 2013) in addition to precursor 
mass:charge ratio (m/z) and retention time. Structural isomers sharing the same m/z, composition, and 
terminal monosaccharide presentation were combined in evaluation of abundance, calculated by integration 
of area under of the curve from extracted ion chromatograms. Abundance values are relative and are 
presented as combined mean ± SEM from 3 biological replicates, each with 3 technical replicates. * Denotes 
doubly charged fragments. Glycans are represented using conventional graphical nomenclature (Varki et 




3.3.3. Removal of terminal mannose and sialic acid residues from pharyngeal cell 
surface glycans differentially impacts the capacity of M12 GAS to form biofilm. 
3.3.3.1. Initial adherence, biofilm biomass, and bacterial colony forming units 
Oligomannose, sialic acid, and galactose were found to comprise the major N-linked 
glycans on the surface of Detroit 562 pharyngeal cells. Sialic acid is utilised by several 
pathogens at the nasopharynx in colonisation and biofilm formation (Parker et al., 2009, 
Trappetti et al., 2009). Due to the abundance of mannose, and the previously described 
importance of sialic acid in bacterial virulence, the role of these structures in GAS biofilm 
formation was further explored. 
To do so, Detroit 562 pharyngeal monolayers were first pre-treated with specific 
exoglycosidases; α1-6 mannosidase (removes α1-6 linked mannose residues), α1-2,3 
mannosidase (removes α1-2 and α1-3 linked mannose residues), and the broad specificity 
sialidase (which will be referred to as Sialidase A) (removes linear and branched terminal 
α2-3, α2-6, α2-8, and α2-9 linked sialic acid); and monosaccharide removal was 
confirmed by lectin binding assays (see Appendix E, Figure E). Initial adherence of 
planktonic GAS after 2 h incubation with the untreated and exoglycosidase pre-treated 
monolayers was determined. The biofilms formed on these monolayers were assessed for 
biofilm biomass and bacterial colony forming units (Fig 3.4A). Investigation into the 
initial adherence of planktonic M12 GAS interacting with the exoglycosidase pre-treated 
and control monolayers found no significant differences (Fig 3.4B). Despite this, the         
72 h M12 GAS biofilms exhibited increased biomass on the exoglycosidase pre-treated 
monolayers compared to the untreated control (Fig 3.4C). Notably, α1-6 mannosidase and 
Sialidase A pre-treatment of monolayers resulted in significant increases (p ≤ 0.05) in 
biofilm biomass. The number of colony forming units within the biofilms did not differ 




Syto9/PI (Fig 3.4E) revealed a significant increase in the number of dead cells within 














































































































































































Figure 3.4. Pre-treatment of pharyngeal cell surface with α1-6 mannosidase and Sialidase A results 
in significantly increased M12 GAS biofilm biomass. (A) Assay schematic for the characterisation of 
biofilms formed on each of the exoglycosidase (α1-6 mannosidase, α1-2,3 mannosidase, and Sialidase A) 
pre-treated pharyngeal monolayers vs. untreated. (B) Initial adherence enumerated for planktonic GAS 
upon 2 h incubation. 72 h biofilms are assessed for (C) biofilm biomass via crystal violet staining and 
viability by (D) colony forming units via enumeration and (E) live/dead staining with Syto9/PI. Data 
represents mean ± SEM, with statistical analysis performed using a one-way ANOVA with Tukey’s 
multiple comparisons test * (p ≤ 0.05); n = 3 biological replicates, with 3 technical replicates each. 
3.3.3.2.  Biofilm EPS 
Biofilms are comprised of bacterial cells and EPS. To further determine what may be 
contributing to the observed changes in biofilm biomass, EPS associated sulphated 
GAGs, extracellular DNA (eDNA), and protein was assessed (Fig 3.5A). 
1,9 dimethyl methylene blue (DMMB) staining was used to detect EPS-associated 
sulphated GAGs (Peeters et al., 2008, Pantanella et al., 2013). EPS associated sulphated 
GAGs increased significantly for M12 GAS biofilms formed on α1-6 mannosidase             
(p ≤ 0.01) and Sialidase A (p ≤ 0.05) pre-treated pharyngeal cell monolayers compared 
to the untreated control (Fig 3.5B). This result supports the findings from crystal violet 
staining, suggesting EPS production increases in response to modification of cell surface 
glycans. Lastly, EPS was examined for common EPS components (eDNA and protein), 
via fluorescent stains Sytox Blue and SYPRO Ruby (Fig 3.5C). There were no significant 






























































Figure 3.5. Biofilm EPS increases significantly for biofilms formed on α1-6 mannosidase and 
Sialidase A pre-treated pharyngeal cell surfaces. (A) Assay schematic for the assessment of biofilm EPS 
resulting from biofilm formed on each of the exoglycosidase (α1-6 mannosidase, α1-2,3 mannosidase, and 
Sialidase A) pre-treated pharyngeal monolayers vs. untreated. 72 h biofilms were assessed for (B) EPS via 
DMMB staining of sulphated GAGs and (C) EPS associated components (eDNA and protein) via 
fluorescent staining with Sytox Blue and FilmTracer SYPRO Ruby biofilm matrix stain, respectively. Data 
represents mean ± SEM, with statistical analysis performed using a one-way ANOVA with Tukey’s 
multiple comparisons test * (p ≤ 0.05) and ** (p ≤ 0.01); n = 3 biological replicates, with 3 technical 











































































































To visually investigate the effect of exoglycosidase (α1-6 mannosidase,                                 
α1-2,3 mannosidase, and Sialidase A) pre-treated pharyngeal monolayers on M12 GAS 
biofilm formation, SEM imaging was conducted (Fig 3.6). Biofilms formed on both 
untreated and exoglycosidase pre-treated monolayers show M12 GAS chained cocci 
arranged into three dimensional aggregated structures with EPS matrix material present 
(Fig 3.6A, C, E, and G). Biofilms formed on each of the exoglycosidase pre-treated 
pharyngeal monolayers appear to produce more EPS matrix material associated with the 
aggregated GAS cocci when compared to GAS biofilms formed on the untreated control. 
EPS produced on all GAS biofilms display the distinct forms seen previously, a web-like 
mesh matrix (small black arrows) and a more globular matrix (big black arrows). Both 
extend from the cocci cell surface of these biofilm cells. Untreated and exoglycosidase 
pre-treated Detroit 562 pharyngeal monolayers (without biofilms) were also imaged as 
controls to ensure that each exoglycosidase treatment did not affect pharyngeal cell 




















Figure 3.6. Visual inspection of 72 h M12 GAS biofilms captured via SEM revealed substantial EPS 
present in biofilms formed on exoglycosidase pre-treated pharyngeal cell monolayers. Images are 
representative of biofilms formed on (A) untreated, (C) α1-6 mannosidase, (E) α1-2,3 mannosidase, and 
(G) Sialidase A pre-treated pharyngeal monolayers. GAS biofilms show chained cocci (white arrows) 
arranged into three dimensional aggregated structures with EPS matrix material present (big and small 
black arrows). SEM images of (B) untreated, (D) α1-6 mannosidase, (F) α1-2,3 mannosidase, and (H) 
Sialidase A pre-treated Detroit 562 pharyngeal cell monolayers (without biofilms) are also included. 
Biofilms and Detroit 562 pharyngeal cell monolayers (without biofilm) were imaged using the JEOL JSM-
7500 microscope at 15,000× and 500× magnification, respectively. SEM images were randomly selected 
and represent two biological replicates with two technical replicates each. 
3.3.4. Increased biofilm formation promotes penicillin tolerance 
Penicillin is the antibiotic of choice for the treatment of GAS infections (Wessels, 2016). 
The biofilm phenotype is known to decrease bacterial susceptibility to antibiotics and is 
suspected to play a role in the observed antibiotic treatment failure rate of 20–40% of 
GAS pharyngitis cases (Facinelli et al., 2001, Conley et al., 2003, Baldassarri et al., 2006). 
As such, the penicillin susceptibility of the M12 GAS biofilms was assessed. 
Firstly, the susceptibility of planktonic M12 GAS to penicillin was confirmed by 
determining the minimum inhibitory concentration (MIC) and minimum bactericidal 




Appendix F, Figure F). A MIC and MBC of 0.025 μg/mL was established, which is 
consistent with the reported GAS MIC and MBC range for penicillin (Çiftçi et al., 2003, 
Sakata, 2013). Notably, minimum biofilm eradication concentration values (MBECs) 
determined for M12 GAS biofilms formed on untreated and exoglycosidase pre-treated 
monolayers (Table 3.1) were all considerably higher than the MIC for planktonic M12 
GAS, resulting in 2500–5000-fold greater penicillin tolerance. Specifically, biofilms 
formed on untreated pharyngeal monolayers had an MBEC of 62.5 μg/mL, whereas 
biofilms formed on exoglycosidase pre-treated monolayers had an MBEC of 125 μg/mL. 
Table 3.1. M12 GAS biofilms exhibit enhanced penicillin tolerance when formed upon 
exoglycosidase-treated pharyngeal cell monolayers. MBECs (μg/mL) determined for M12 GAS biofilms 
were compared to the planktonic M12 GAS minimum inhibitory concentration (MIC) (0.025 μg/mL). Data 




Fold Greater Tolerance 
Compared to MIC 
Untreated 62.5 2500 
α1-6 mannosidase 125 5000 
α1-2,3 mannosidase 125 5000 
Sialidase A 125 5000 
 
3.4. Discussion 
Pharyngitis is the most prevalent form of GAS disease (Carapetis et al., 2005, Wessels, 
2016). Although other pathogenic agents can cause pharyngitis, GAS is frequently 
isolated in affected children (20–40%) and adolescents/young adults (5–15%) (Conley et 
al., 2003, Danchin et al., 2007). Penicillin is the antibiotic of choice due to its narrow 
spectrum of activity, safety, and accessibility (Wessels, 2016). Most notably, there have 
been no reported cases of GAS resistance to penicillin to date among clinical isolates. 
Despite this, antibiotic treatment failure occurs in 20–40% of cases (Kuhn et al., 2001, 
Conley et al., 2003). Numerous hypotheses have been suggested to explain this treatment 
failure rate including GAS host-cell internalisation and viral/bacterial co-pathogenicity 
(Österlund et al., 1997, Pichichero and Casey, 2007). More recently, it has been proposed 
that GAS may exist as a biofilm, a microbial phenotype that is known to provide 




2011, Marks et al., 2014). Numerous studies have since investigated biofilm formation in 
the context of GAS pharyngitis and treatment failure. However, many of them employ 
abiotic substrata, and moreover, none have considered the role of host cell surface 
glycans. Given the increasingly appreciated importance of glycans in the host-pathogen 
relationship and the abundance of glycosylated structures in the oropharynx, this work 
contributes to an improved understanding of the role of host glycans in the pathogenesis 
of GAS pharyngitis and antibiotic treatment failure. 
Interactions of planktonic GAS with a variety of glycan structures have been observed in 
numerous studies, many of which indicate that host glycans are implicated in GAS 
binding and adhering to host cells (Frick et al., 2003, De Oliveira et al., 2017, De Oliveira 
et al., 2019). In the current study, removal of N-linked glycans from the Detroit 562 
pharyngeal cell surface significantly decreased initial adherence of planktonic M12 GAS. 
Despite this, subsequent M12 GAS biofilms displayed a significant increase in biofilm 
biomass on PNGase F treated cells. SEM imaging of biofilms formed on both untreated 
and PNGase F pre-treated monolayers revealed adherent M12 GAS cocci chains arranged 
in three dimensional aggregated structures intermeshed with EPS matrix. Moreover, 
biofilms formed on PNGase F pre-treated monolayers were seen to have more EPS 
matrix. Two varieties of EPS matrix were visible; the globular EPS matrix seen in the 
current study is phenotypically similar to GAS biofilms imaged via SEM previously on 
the surface of tonsils removed from patients with recurrent GAS tonsillopharyngitis 
(Roberts et al., 2012). The web-like EPS matrix projecting from the cocci cell surface of 
these biofilms has been captured in one previous study of M2 GAS biofilms, with the 
authors describing the EPS matrix material as “threadlike structures of an as-yet unknown 
chemical composition” (Lembke et al., 2006). 
Although this is an interesting finding, it is unlikely in vivo that a host cell surface would 




specific N-linked glycans that are abundant on the Detroit 562 pharyngeal cell surface in 
this study. PGC-LC-ESI-MS/MS analysis of the Detroit 562 pharyngeal cell surface N-
glycome revealed that oligomannose structures are the most abundant class of N-glycan, 
followed by complex and hybrid glycans, with mannose being the predominant 
monosaccharide on the cell surface. As mannosidases act upon oligomannose N-glycans 
primarily, and hybrid N-glycans secondarily, broad-spectrum sialidase treatment was 
additionally utilised in this study to act upon complex and hybrid N-glycans. Removal of 
terminal mannose and sialic acid residues resulted in an increase of biofilm biomass 
similar to that induced by total N-glycan removal with PNGase F, independent of initial 
adherence and enumerated biofilm viability. It is possible that removal of these glycans 
enables access by GAS to otherwise impeded host receptors involved in the host-pathogen 
interaction, further promoting biofilm formation. The importance of terminal 
monosaccharides has been demonstrated in a previous study of GAS binding to human 
buccal epithelial (HBE) cells, whereby expression of terminal galactose and sialic acid 
residues had significant effects on M1, 3, and 12 associations, whilst terminal fucose and 
N-acetylgalactosamine were of comparatively lesser dependence of binding for all three 
GAS M-types. It was suggested that fucose and N-acetylgalactosamine may have a host-
protective effect, sterically hindering access to the preferred galactose residues (De 
Oliveira et al., 2019). Many pathogens are known to possess their own suite of 
glycosidases which they utilise to liberate glycan residues for their own metabolic 
processes, and moreover, to better access preferred glycan structures for adherence 
(Grewal et al., 2008, Inui et al., 2015). For example, S. pneumoniae expresses multiple 
neuraminidases that cleave off sialic acids, unmasking other receptors for increased 
binding and virulence (Grewal et al., 2008). 
To further assess viability, particularly the dead cell populations within these biofilms, 




stains nucleic acids of cells with compromised membranes. When used together at 
appropriate concentrations, PI is in excess to Syto9 and with its overall higher binding 
affinity towards nucleic acids will displace Syto9. As such, dead cells can be 
distinguished from total cell population (Robertson et al., 2019, Rosenberg et al., 2019). 
Pre-treatment with α1-6 mannosidase and Sialidase A resulted in biofilms comprising a 
significantly greater proportion of dead cells. However, these results conflict with the 
findings of the biofilm viability determined via enumeration. Although Syto9 and PI are 
routinely used for staining live/dead cells, it is understood that there are some limitations 
which may lead to an erroneous and inaccurate depiction of viability. Specifically, over 
or underestimation of live or dead cells may result from poorer penetration of the dyes 
for bacteria grown in nutrient-rich media and variation in bacterial membrane integrity 
resulting from differing physiological growth states (Stiefel et al., 2015, Robertson et al., 
2019). More importantly, eDNA, which is a well-established component of many 
microbial biofilms, is also stained by these dyes (Rosenberg et al., 2019). Taken together 
it is likely that the dead cell population has been overestimated. Future study should 
consider a combination of methods to accurately estimate viability; utilising stains for 
metabolic activity and visualisation of these biofilms via confocal laser scanning 
microscopy (CLSM) or super-resolution microscopy. Additionally, given the limitations 
presented by culture-based methods (i.e. some species existing in a viable, but non-
cultivable state), culture-independent techniques may also be of use. Specifically, 
quantitative real-time PCR (qPCR) which can rapidly detect these viable but otherwise 
non-cultivable cells, and thus give a better representation of the biofilm viability 
(Magalhães et al., 2019). 
Given that initial planktonic GAS adherence and the population of live cells as 
determined via enumeration within the biofilms did not seem to uniquely contribute to 




of the biofilm, and it is thought to contribute to around 80–85% of the total biofilm 
biomass (Cowan, 2011). The removal of glycans did not result in an increase of initial 
bacterial adherence, and it is possible changed glycan structures modified expression of 
genes associated with EPS production, although this was not explored in the current 
study. The EPS matrix has its own complex and dynamic matrixome, which defines the 
compositional and functional diversity of the EPS. EPS is predominantly comprised of 
polysaccharides, proteins, eDNA, and lipids. Despite variability in their composition 
across pathogens, EPS-associated polysaccharides are generally considered the most 
abundant (Flemming and Wingender, 2010, Bales et al., 2013, Karygianni et al., 2020). 
Currently, GAS EPS remains poorly defined, with only one study having investigated 
EPS polysaccharides, determining that L-glucose and D-mannose were the most abundant 
sugar moieties of the EPS of one M6 strain (Shafreen et al., 2011). 
DMMB staining is a simple approach that has been used extensively in staining the EPS 
GAG polysaccharides of numerous other bacterial biofilms (e.g., Staphylococcus aureus, 
P. aeruginosa, Burkholderia cenocepacia, and Propionibacterium acnes) (Peeters et al., 
2008, Pantanella et al., 2013). Here, for the first time, it is demonstrated that DMMB is 
suitable for detecting GAS biofilm EPS-associated GAGs. Moreover, DMMB staining 
revealed that biofilms formed on α1-6 mannosidase and Sialidase A pre-treated 
pharyngeal monolayers exhibited significantly increased EPS polysaccharide production, 
despite eDNA or protein abundance remaining unchanged. Further assessment of other 
EPS components such as lipids and a diverse range of polysaccharides should be 
investigated via other fluorescent stains such as 1,1′-dioctadecyl-3,3,3′,3′-
tetramethylindodicarbocyanine perchlorate (DiD’oil) or concanavalin A conjugated to a 
fluorophore such as tetramethylrhodamine (González-Machado et al., 2018). SEM 
imaging of biofilms formed on both untreated and each of the exoglycosidase pre-treated 




monolayers. Biofilms show adherent M12 GAS cocci chains arranged in three 
dimensional aggregated structures intermeshed with EPS matrix. Similar to results 
following PNGase F treatment, biofilms formed on exoglycosidase pre-treated 
pharyngeal cell monolayers showed an increase in EPS matrix. Both varieties of EPS 
(globular and web-like) were present in biofilms formed. 
A critical characteristic of the biofilm phenotype is increased tolerance to antimicrobials, 
with reports of antimicrobial tolerance anywhere between 10 and >1000 times greater 
compared to planktonic form (Costerton et al., 1999, Donlan and Costerton, 2002, Hall-
Stoodley et al., 2004). Biofilms may be a contributing factor for the antibiotic treatment 
failure rate of 20–40% reported in cases of GAS pharyngitis. Here we determined if the 
observed increase in biofilm formation was functionally relevant in the context of 
penicillin tolerance when compared to planktonic GAS. Penicillin tolerance doubled 
following removal of mannose and sialic acid residues, respectively, from the pharyngeal 
monolayer substratum. We have shown that removal of these residues leads to increases 
in EPS which may have impeded penicillin penetration through the biofilms. Several 
other features unique to the biofilm phenotype may have further contributed to the 
increase in penicillin tolerance including differential growth rates of bacterial cells, 
nutrient gradients, and antibiotic degradation once in the biofilm (Costerton et al., 1995, 
Stewart and William Costerton, 2001, Høiby et al., 2010, Lewis, 2010). Further study 
should aim to characterise the specific mechanisms for the enhanced penicillin tolerance 
described here. 
The indiscriminate removal of all N-glycans and the targeted removal of terminal 
mannose and sialic acid, which predominate the surface of Detroit 562 pharyngeal cells, 
increases biofilm biomass, specifically via increased EPS production. The presence of 
certain host glycan structures may be a host-protective mechanism, reducing the 




via recently discovered glycosidases endoglycosidase S and α-mannosidase (Collin and 
Olsén, 2001, Suits et al., 2010). The ability of GAS to modify the host-glycome at 
different sites and stages of infection has not been characterised. Our findings suggest 
that modification of the host glycome during the course of infection may increase the 
ability of GAS to form biofilms. 
GAS is commonly attributed to pharyngeal infection with over 600 million cases per year, 
presenting a considerable global burden (Carapetis et al., 2005). Recurrent GAS infection, 
persistent carriage, and antibiotic treatment failure remain challenging and unresolved, 
despite numerous efforts in characterising the consortia of molecular mechanisms 
underpinning GAS virulence and pathogenesis. Moreover, most of these studies have 
been conducted only in the context of planktonic GAS. Here GAS biofilm formation has 
been investigated for the first time, with a particular focus on the effect of altering 
pharyngeal cell surface glycans. Host cell surface glycans may offer a protective 
advantage against GAS biofilm formation. We have shown that modulation of the 
pharyngeal glycome has a direct impact on GAS biofilm formation, with increases in EPS 
likely to play an important role. Moreover, the increased GAS biofilms displayed 
significantly greater penicillin tolerance dependent on the host cell glycome. Lastly, this 
study described the effect of host glycosylation on GAS biofilm formation and GAS 




Chapter 4: Assessing the role pharyngeal cell surface glycans play in 
GAS biofilm formation for a diverse set of GAS serotypes 
Overview: Previously, M12, a prominent pattern A-C GAS M-type contributing to global 
pharyngeal infection (Walker et al., 2014) was assessed for its biofilm forming abilities 
in response to changes in Detroit 562 pharyngeal cell surface mannose and sialic acid 
availability. Here, a diverse range of GAS M-types representative of distinct emm patterns 
A-C, D, and E were similarly assessed for their biofilm formation. Modulation of the 
pharyngeal glycome directly impacted GAS biofilm formation of all eight GAS M-types 
in a strain- and glycan- dependent manner. M-types were grouped by their emm patterns 
to identify correlations between emm pattern and GAS biofilm formation response to 
changes in Detroit 562 pharyngeal cell surface glycan profile modifications. With the 
exception of pattern E GAS M-types, variances in biofilm formation in response to 
differentially exposed pharyngeal cell surface glycans were not emm pattern specific. 
Further investigation is warranted into other factors that may be contributing biofilm 
formation at the pharyngeal glycan surface, such as non-M GAS virulence factors, biofilm 
specific mechanisms (e.g. quorum sensing) and so forth. Overall, the findings of this work 
suggest that altering the pharyngeal cell surface glycome results in biofilm potentiation 
of a diverse selection of GAS M-types. These findings underscore the importance of the 
glycomic landscape of the host in mediating GAS biofilm formation.  
4.1. Introduction 
Of the plethora of virulence factors produced by GAS, the M protein is a major virulence 
factor that is abundantly expressed on the surface of GAS (Walker et al., 2014). The M 
protein is well characterised and has been found to play a role in adhesion to the host cell 
surface for a variety of GAS strains (Ellen and Gibbons, 1972, Tylewska et al., 1988, 
Caparon et al., 1991). The 5’ region of the emm gene that encodes the M protein has 




typing has led to the identification of over 200 differing GAS emm types (Smeesters et 
al., 2010, Walker et al., 2014). Although their distribution is in part impacted by 
geographic and socioeconomic factors, the predominance of certain emm types in discrete 
geographical locations is widely reported.  In industrialised regions, M-types 1, 3, and 12 
predominate, and underpin ~40% of GAS disease (Steer et al., 2009). Moreover, 
epidemiological studies have found distinct M-types have been heavily associated with 
various disease manifestations, for example, M-types 2 and 44/61 are linked to superficial 
disease, whereas M-types 1 and 3 are associated with invasive disease (Ekelund et al., 
2005, Shea et al., 2011).  
The genetic variability in the emm gene consequently confers diversity in protein function 
and binding ligands among each distinct GAS M-type. This can be seen in the varying 
abilities of differing GAS M-types to adhere to- and internalise at- distinct epithelial 
tissues of the pharynx and/or skin (Bessen and Lizano, 2010). Decades of epidemiological 
study have found strong associations between M-types and the bodily niche they occupy, 
and the subsequent disease manifestations they cause (Wannamaker, 1970, Bessen et al., 
1996, Bessen and Lizano, 2010). This has led to the identification of distinct throat, skin, 
and generalist strains (Bessen and Lizano, 2010). Further investigation has found an 
association between the emm gene and emm-family (M-related protein encoded by mrp 
and M-like protein encoded by enn) located within the multiple gene activator (Mga) 
regulon and GAS tissue tropism. This has led to an additional GAS typing system, the 
‘emm pattern’ typing system, that comprises five distinct patterns (Fig 4.1) (Hollingshead 
et al., 1994). GAS M-types belonging to Patterns A-C are thought to be associated with 
pharyngeal infections, Pattern D with infections of the skin, and Pattern E are termed 
generalist and are associated with infections in both the pharynx and skin (Bessen and 
Lizano, 2010). This was supported in a 2004 study of over 4000 GAS isolates, in which 




of the throat, and those belonging to pattern D emm type were highly likely to cause 
impetigo lesions of the skin (McGregor et al., 2004).  
 
Figure 4.1. GAS Emm pattern system is underpinned by the genomic arrangement of the multiple 
gene activator (Mga) regulon. The Mga regulon comprises of the M protein family; M-related protein 
(encoded by mrp), M-protein (encoded by emm), and M-like protein (encoded by enn). The scpA (encoding 
c5a peptidase) is located downstream of the M protein family genes. Together these are thought to 
contribute to tissue tropism and have been assigned to each respective Emm pattern as follows; pharyngeal 
tissue (Pattern A-C), skin tissue (Pattern D), and generalist which can associate to both pharyngeal and skin 
tissue (Pattern E). Pattern E strains uniquely possess a sof gene located downstream of the mga regulon, 
which secretes serum opacity factor. Figure is adapted from Hollingshead et al. (1994), Bessen and Lizano 
(2010).  
 
The diversity of the emm gene also contributes to differential binding of host extracellular 
matrix components (fibrinogen, fibronectin, albumin etc) and host antibodies (Smeesters 
et al., 2010, Sanderson-Smith et al., 2014). Interestingly, emm patterns can confer 
exclusive M protein binding profiles which may further contribute to differential tissue 
tropism (Bessen, 2016). For example, pattern A-C M proteins primarily bind fibrinogen, 
pattern D M proteins primarily bind plasminogen, and pattern E M proteins primarily 
bind IgA antibody and the complement component 4 binding protein (Smeesters et al., 
2010).  
Glycans have been shown to be ligands for a small number of pattern A-C associated M 
proteins (M1, 3, and 12). Frick et al. (2003) demonstrated that M1 GAS could bind Detroit 
562 pharyngeal cells via surface-expressed GAGs dermatan sulfate and/or heparan 




cells with varying affinities via A, B, and O(H) histo-blood group antigens, with 
recognition of the H antigen and association of M1 GAS to H-antigen expressing cells 
notably higher than for other histo-blood group antigens. In a more recent study by De 
Oliveira et al. (2019), analysis of glycan binding by M proteins was expanded to include 
A-C M proteins of M3 and M12. It was found that M3 and M12 colonisation of HBE 
cells was also mediated in part by human histo-blood group antigens and Lewis antigens. 
M3 and M12 GAS had the greatest association with HBE cells expressing H antigen, 
followed by HBE cells expressing A antigen (De Oliveira et al., 2019). These studies 
provide strong evidence that host glycans play an important role in GAS colonisation, 
however, they are limited to studying planktonic GAS belonging to pattern A-C emm 
types. 
As outlined in chapter 3, the removal of distinct mannose and sialic acid residues from 
the Detroit 562 pharyngeal cell surface via α1-mannosidase and a broad specificity 
sialidase (Sialidase A) significantly increased the ability of M12 GAS to form biofilms. 
Given the diversity of M proteins, the known association between emm pattern and 
tropism, and the high rates of disease globally caused by these diverse emm types, it is 
important to study a broader variety of GAS M-types. Here, the biofilm forming abilities 
of other throat tropic pattern A-C GAS M-types (M1 and M3), as well as several 
representative pattern D and E M-type strains were assessed in response to pharyngeal 
cell surface glycan removal.  
The aim of this chapter is to determine if changes in biofilm formation in response to an 
altered pharyngeal glycomic landscape is common to a diverse selection of GAS M-types. 
GAS M-types were categorised into their representative emm pattern to further 
understand if the bodily niche associated with these emm types elicited any further effects 
on biofilm formation. Such research will broaden the understanding of GAS biofilms in 




4.2. Materials and methods 
Methods used for the assessment of other GAS M-types in this chapter are those 
established and defined in the previous chapter (Chapter 3, Section 3.2) for M12 GAS 
biofilm formation in response to pharyngeal cell surface glycans. As such, they are 
presented here in brief. Moreover, the assays used to evaluate the effect pharyngeal cell 
surface glycans exert on the diverse range of GAS M-types and the emm patterns they 
represent in forming biofilms have further been summarised in the schematic (Fig 4.2). 
 
Figure 4.2.   Schematic outlining the methods used for the assessment of pharyngeal cell glycan’s 




4.2.1. GAS and culture conditions 
GAS strains used in this study (Table 4.1) are clinical GAS isolates, with each strain 
representative of a discrete GAS emm-type (Aziz et al., 2004, McKay et al., 2004, Johnson 
et al., 2002, Sanderson-Smith et al., 2014). GAS was grown on either HBA plates or THYA 
where appropriate. Static cultures of GAS were grown overnight in THY. GAS was 
cultured and maintained at 34°C (Marks et al., 2012). 
Table 4.1. GAS strains used in this study have been categorised by their emm patterns; A-C, D, and 
E. The table further details strain M-types, strain identity, and clinical source (Johnson et al., 2002, Aziz et 
al., 2004, McKay et al., 2004, Maamary et al., 2010, Sanderson-Smith et al., 2014, De Oliveira et al., 2019). 
Pattern M-type Strain  Clinical source 
A-C 
M1 5448  Invasive infection: Necrotising fasciitis and toxic shock 
M3 90254  Invasive infection 
D 
M53 NS13  Invasive infection: Blood (bacteraemia) 
M98 NS88.2  Invasive infection: Blood (bacteraemia) 
M108 NS50.1  Superficial infection: Wound 
E 
M9 NS179  Invasive infection: Pustules on foot (bacteraemia) 
M44 NS297  Superficial infection: skin sore 
M90 NS730  Invasive infection: Necrotising fasciitis, hip pus 
4.2.2. Human pharyngeal cell culture conditions, monolayer formation, and 
exoglycosidase pre-treatment 
4.2.2.1. Human pharyngeal cell culture conditions 
Detroit 562 pharyngeal epithelial cells were cultured in DMEM F12, supplemented with L-





4.2.2.2. Pharyngeal cell monolayer formation 
Wells of 96-well flat bottom cell culture microtiter plates were coated with Collagen I from 
rat tail and incubated for 1 h (37˚C, 5% CO2 – 20% O2 atmosphere). After 1 h, wells were 
seeded with 150 µL Detroit 562 cell suspension (2x105 cells/mL) and cultured for 48 h to 
form monolayers. Monolayers were washed once with PBS and fixed with sterile 3.7 % 
PFA for 20 min. Fixed monolayers were washed with PBS, and monolayers kept wet via 
submersion in PBS until required for use.  
4.2.2.3. Exoglycosidase: α1-6 mannosidase, α1-2,3 mannosidase, and 
Sialidase A treated monolayers 
Fixed pre-formed Detroit 562 pharyngeal cell monolayers of the 96-well microtiter plate 
were treated with 30 µL/well reaction volumes of each of the exoglycosidases; α1-6 
mannosidase, α1-2,3 mannosidase, and Sialidase A. Untreated PBS wells representing the 
intact surface glycome of the Detroit 562 pharyngeal cell monolayers were also included 
as a control. The plate was incubated for 2 h, 37℃. Once incubated, the wells were washed 
once with PBS. 
4.2.3. Initial adherence of planktonic GAS 
Fixed pre-formed Detroit 562 pharyngeal cell monolayers were inoculated with 150 µL of 
stationary phase GAS culture diluted 1:20 in THY-G and incubated for 2 h to promote 
initial attachment (34°C, slow shaking at 50 rpm). At 2 h, non-adherent GAS was removed, 
and the wells washed thrice with PBS. To detach Detroit 562 cells from the bottom of the 
microtiter plate, trypsin-EDTA was added to each well and incubated (15 min, 37°C). To 
lyse the now-detached Detroit 562 cells containing internalised bacteria, Triton X-100 was 
added and pipetted vigorously. To enumerate the adherent GAS population, 10-fold serial 




THYA (incubated overnight, 34°C) for subsequent colony counting and CFU/mL 
determination. 
4.2.4. GAS biofilms  
96-well microtiter plates containing pre-formed fixed Detroit 562 pharyngeal cell 
monolayers untreated and pre-treated with exoglycosidases were inoculated with 150 µL 
of overnight GAS culture diluted 1:20 in THY-G. The inoculum was incubated for 2 h 
(34°C, 50 rpm). At 2 h, non-adherent GAS was removed, and wells replenished with sterile 
THY-G. Subsequent 72 h GAS biofilms were produced (34°C, 50 rpm), with sterile THY-
G media refreshment performed every 24 h. 
4.2.4.1. GAS biofilm biomass crystal violet staining 
Biofilm biomass was assessed via crystal violet staining. Air dried biofilms were fixed with 
99% methanol and stained with crystal violet for 10 min (RT, static). Once stained, excess 
crystal violet was removed and each well gently washed twice with PBS. Crystal violet 
stain that had incorporated into the biofilm was re-solubilised in 1% SDS (w/v), and 
incubated (10 min, RT). Monolayers with THY-G (and no GAS biofilm) doubled up as 
media sterility controls and blanks. Biofilm biomass quantification was performed by 
diluting the released dye 1:5 in the 1% SDS solution, and subsequently measured at OD540nm 
using a SpectraMax Plus 384 microplate reader. 
4.2.4.2. GAS biofilm cell viability 
GAS biofilms were assessed for viability via enumeration of serially diluted biofilms. 
Briefly, biofilms were washed once in PBS and thoroughly re-suspended in fresh PBS. 
Viable cells were enumerated via 10-fold serially diluting in PBS, and spot plating onto 





4.2.4.3. GAS biofilm EPS 
To assess biofilm EPS, the i) EPS-GAGs and ii) common EPS components (eDNA and 
protein) were examined. Briefly, EPS associated S-GAGs were quantified by 1,9-dimethyl 
methylene blue (DMMB) dye-based EPS assay. EPS components (eDNA and protein) were 
fluorescently stained with Sytox™ Blue, a cell membrane-impermeant nucleic acid stain 
and FilmTracer™ SYPRO® Ruby biofilm matrix stain that labels most classes of proteins. 
4.2.4.4. Scanning electron microscopy 
GAS biofilms were grown on untreated and exoglycosidase pre-treated fixed monolayers 
on 13 mm plastic Nunc Thermanox coverslips in a 12-well polystyrene plate. Biofilms 
were pre-fixed for 30 min (4°C), and further fixed for 1.5 h (4°C). Post-fixation of 
biofilms was conducted using 2% osmium tetroxide vapour (2 h). A graded ethanol series 
was then used, and samples were critical point dried. Dried samples were then sputter 
coated with platinum and visualised using a JEOL JSM-7500 microscope at 15 000 x 
magnification. Untreated and exoglycosidase pre-treated Detroit 562 pharyngeal 
monolayer controls (without biofilms) were also imaged at 5000 x magnification. Images 
were taken at random positions within the samples by an UOW Electron Microscopy 
Centre technician blinded from the study in an effort to reduce bias. 
4.2.5. Statistical analysis 
All statistical analysis was performed using GraphPad Prism. One-way ANOVA was 
performed with a Tukey’s multiple comparisons post hoc test. A p-value of ≤ 0.05 was 





4.3.1. Pattern A-C GAS M-types 
4.3.1.1. Initial adherence, biofilm biomass, and bacterial colony forming 
units  
M12 GAS is an emm pattern A-C family member (Bessen et al., 1989). Previously, M12 
biofilm formation on exoglycosidase (α1-6 mannosidase, α1-2,3 mannosidase, and 
Sialidase A) pre-treated vs untreated Detroit 562 pharyngeal cell monolayers was 
investigated. Findings suggested M12 biofilm biomass significantly increased on α1-6 
mannosidase and Sialidase A pre-treated surfaces. Whilst this increase in biofilm biomass 
was independent of initial planktonic M12 GAS adherence and bacterial colony forming 
units, EPS was found to likely be involved.  
M1 and M3, are commonly associated with GAS pharyngitis and have been deemed 
major contributors to high global pharyngeal infection rates (Walker et al., 2014). Here, 
these two Pattern A-C GAS M-types have been assessed for biofilm formation to see if 
pattern classification correlates with changes in biofilm formation following the removal 
of mannose and sialic acid residues.  
Investigation of the initial adherence of planktonic M1 and M3 GAS interacting with the 
exoglycosidase (α1-6 mannosidase, α1-2,3 mannosidase, and Sialidase A) pre-treated and 
control monolayers found no significant differences (Fig 4.3A). Despite this, the 72 h M1 
and M3 GAS biofilms exhibited increased biomass on the exoglycosidase pre-treated 
monolayers compared to the untreated control (Fig 4.3B). Notably, for both M1 and M3 
GAS biofilms formed on α1-2, 3 mannosidase, there was a significant increase (p ≤ 0.05) 
in biofilm biomass. M1 also displayed a significant increase in biofilm biomass when 
grown on Sialidase A pre-treated monolayers. The number of colony forming units within 

































































































Figure 4.3. Pattern A-C GAS M-types M1 and M3 assessed for their biofilm formation on 
exoglycosidase pre-treated Detroit 562 monolayers. (A) Initial adherence enumerated for planktonic 
GAS following 2 h incubation. 72 h biofilms were assessed for (B) biofilm biomass via crystal violet 
staining and (C) colony forming units via enumeration. Data represents mean ± SEM, with statistical 
analysis performed using a one-way ANOVA with Tukey’s multiple comparisons test * (p ≤ 0.05) and ** 
(p ≤ 0.01); n = 3 biological replicates, with 3 technical replicates each 
4.3.1.2. Biofilm EPS 
Biofilms are comprised of microbial cells and EPS. To further determine what may be 
contributing to the observed changes in biofilm biomass, EPS associated sulphated GAGs 
(S-GAGs), extracellular DNA (eDNA), and protein was assessed.  
DMMB staining of EPS associated S-GAGs found no significant differences in EPS for 
M1 biofilms formed on any of the monolayers (Fig 4.4A). However, M3, was found to 
increase in EPS S-GAG content for biofilm formed on α1-6 mannosidase pre-treated 
monolayers (Fig 4.4A). As such, M3 EPS was further examined for eDNA and protein 




































































significant differences in the presence of EPS associated eDNA or protein in any of the 





















































































Figure 4.4. M3 has significantly increased EPS (S-GAGs) when biofilms were formed on α1-6 
mannosidase pre-treated pharyngeal cell monolayers. M1 and M3 Biofilms were assessed for (A) EPS 
via DMMB staining of sulphated GAGs. (B) M3 biofilm EPS was further inspected for its EPS associated 
components (eDNA and protein) via fluorescent staining with Sytox™ Blue and FilmTracer™ SYPRO® 
Ruby biofilm matrix stain, respectively. Data represents mean ± SEM, with statistical analysis performed 
using a one-way ANOVA with Tukey’s multiple comparisons test ** (p ≤ 0.01); n = 3 biological replicates, 




































































4.3.1.3. Visualisation of M3 GAS biofilms 
Given the significant increases in M3 EPS for biofilms formed on α1-6 mannosidase pre-
treated monolayers, M3 biofilms formed on untreated and exoglycosidase pre-treated 
monolayers were further investigated via SEM imaging. M3 GAS biofilms formed on 
both untreated and exoglycosidase pre-treated monolayers show distinct, long cocci 
chains arranged into three dimensional aggregated structures with EPS matrix material 
present (Fig 4.5A, C, E, and G). Biofilms formed on each of the pharyngeal monolayers 
appear to produce EPS matrix material associated with the aggregated GAS cocci. 
However, no significant differences were visually apparent in the amount of EPS present 
among biofilms formed. Two varieties of EPS were found, the web-like mesh matrix 
(small black arrows) a more globular matrix (big black arrows). Both appeared to extend 
from the cocci cell surface of these biofilm cells. Untreated and exoglycosidase pre-
treated Detroit 562 pharyngeal monolayers (without biofilms) were also imaged as 
controls to ensure that each exoglycosidase treatment did not affect pharyngeal cell 




















Figure 4.5. Visual inspection of 72 h M3 GAS biofilms captured via SEM reveals substantial EPS 
present in biofilms formed on exoglycosidase pre-treated pharyngeal cell monolayers. Images are 
representative of biofilms formed on (A) untreated, (C) α1-6 mannosidase, (E) α1-2,3 mannosidase, and 
(G) Sialidase A pre-treated pharyngeal monolayers. GAS biofilms show chained cocci (white arrows) 
arranged into three dimensional aggregated structures with EPS matrix material present (big and small 
black arrows). Biofilms were imaged using the JEOL JSM-7500 microscope at 15 000 x magnification. 
Respective Detroit 562 pharyngeal cell monolayer controls; (B) untreated, (D) α1-6 mannosidase, (F) α1-
2,3 mannosidase, and (H) Sialidase A pre-treated were also imaged at 500 x magnification. SEM images 




4.3.2. Pattern D GAS M-types 
4.3.2.1. Initial adherence, biofilm biomass, and bacterial colony forming 
units 
Pattern D strains of GAS are thought to have preference towards colonisation and 
infection of the skin (Bessen and Lizano, 2010). M53 is a known dermal isolate 
implicated in superficial skin diseases (Steer et al., 2009), whilst M98 and M108 are other 
pattern D GAS isolates (Sanderson-Smith et al., 2014), were also assessed for biofilm 
formation on the Detroit 562 pharyngeal cell monolayers.  
Initial adherence of planktonic M53, 98, and 108 to Detroit 562 pharyngeal cell 
monolayers did not differ significantly between exoglycosidase (α1-6 mannosidase,        
α1-2,3 mannosidase, and Sialidase A) pre-treated and untreated monolayers (Fig 4.6A). 
Despite this, all three Pattern D GAS M-types formed biofilms with an increased biomass 
on the exoglycosidase pre-treated monolayers compared to the untreated control (Fig 
4.6B). M98 biofilms formed on all three exoglycosidase (α1-6 mannosidase, α1-2,3 
mannosidase, and Sialidase A) pre-treated monolayers displayed a significant increase     
(p ≤ 0.001) in biofilm biomass compared to biofilm biomass found on untreated control. 
M108 displayed a significant increase in biofilm biomass when grown on α1-2,3 
mannosidase pre-treated monolayers but not on α1-6 mannosidase and Sialidase A pre-
treated monolayers. Despite increases in M53 biofilm biomass when grown on α1-6 
mannosidase, α1-2,3 mannosidase, and Sialidase A pre-treated monolayers, these 
increases were not significant when compared to biofilm biomass formed on untreated 
control cells. The number of colony forming units for all biofilms formed found no 
significant differences between biofilms formed on exoglycosidase pre-treated                 
(α1-6 mannosidase, α1-2,3 mannosidase, and Sialidase A) monolayers compared to 
















































































































Figure 4.6. Pattern D GAS M-types M53, M98, and M108 assessed for their biofilm formation on 
exoglycosidase pre-treated Detroit 562 monolayers. (A) Initial adherence enumerated for planktonic 
GAS following 2 h incubation. 72 h biofilms were assessed for (B) biofilm biomass via crystal violet 
staining and (C) colony forming units via enumeration. Data represents mean ± SEM, with statistical 
analysis performed using a one-way ANOVA with Tukey’s multiple comparisons test ** (p ≤ 0.01) and 
*** (p ≤ 0.001); n = 3 biological replicates, with 3 technical replicates each. 
4.3.2.2. Biofilm EPS 
DMMB staining of EPS associated S-GAGs found no significant differences in EPS for 
M53 or M108 biofilms formed on any of the exoglycosidase (α1-6 mannosidase, α1-2,3 
mannosidase, and Sialidase A) pre-treated monolayers when compared to untreated 
control (Fig 4.7A). However, EPS S-GAGs were found to increase for M98 biofilm 
formed on α1-6 mannosidase pre-treated monolayers (Fig 4.7A). Hence, M98 EPS was 




































































(Fig 4.7B). However, there were no significant differences in the presence of EPS 






















































































Figure 4.7. M98 has significantly increased EPS (S-GAGs) when biofilms were formed on α1-6 
mannosidase pre-treated pharyngeal cell monolayers. M53, 98, and 108 biofilms were assessed for (A) 
EPS via DMMB staining of sulphated GAGs. (B) M98 biofilm EPS was further inspected for its EPS 
associated components (eDNA and protein) via fluorescent staining with Sytox™ Blue and FilmTracer™ 
SYPRO® Ruby biofilm matrix stain, respectively. Data represents mean ± SEM, with statistical analysis 
performed using a one-way ANOVA with Tukey’s multiple comparisons test * (p ≤ 0.05); n = 3 biological 




































































4.3.2.3. Visualisation of M98 GAS biofilms 
M98 EPS was found to increase significantly for biofilms formed on α1-6 mannosidase 
pre-treated monolayers. Hence, M98 GAS biofilm formation on each of the 
exoglycosidase pre-treated and untreated monolayers were further visually inspected via 
SEM imaging. All M98 GAS biofilms were found have GAS cocci chains arranged into 
three dimensional aggregated structures with EPS matrix material present (Fig 4.8A, C, 
E, and G). Biofilms formed on each of the pharyngeal monolayers appear to produce EPS 
matrix material associated with the aggregated GAS cocci. However, no significant 
differences were visually apparent in the amount of EPS present among biofilms formed. 
Two varieties of EPS were found, the web-like mesh matrix (small black arrows) a more 
globular matrix (big black arrows) that extend from the cocci cell surface of these biofilm 
cells. Untreated and exoglycosidase pre-treated Detroit 562 pharyngeal monolayers 
(without biofilms) were also imaged as controls to ensure that each exoglycosidase 




















Figure 4.8. Visual inspection of 72 h M98 GAS biofilms captured via SEM reveals substantial EPS 
present in biofilms formed on exoglycosidase pre-treated pharyngeal cell monolayers. Images are 
representative of biofilms formed on (A) untreated, (C) α1-6 mannosidase, (E) α1-2,3 mannosidase, and 
(G) Sialidase A pre-treated pharyngeal monolayers. GAS biofilms show chained cocci (white arrows) 
arranged into three dimensional aggregated structures with EPS matrix material present (big and small 
black arrows). Biofilms were imaged using the JEOL JSM-7500 microscope at 15 000 x magnification. 
Respective Detroit 562 pharyngeal cell monolayer controls; (B) untreated, (D) α1-6 mannosidase, (F) α1-
2,3 mannosidase, and (H) Sialidase A pre-treated were also imaged at 500 x magnification. SEM images 




4.3.3. Pattern E GAS M-types 
4.3.3.1. Initial adherence, biofilm biomass, and bacterial colony forming 
units  
All three pattern E strains M9, 44, and 90 were assessed for initial adherence to the 
untreated and exoglycosidase (α1-6 mannosidase, α1-2,3 mannosidase, and Sialidase A) 
pre-treated monolayers. However, there were no significant differences in the ability of 
any of the assessed planktonic GAS M-types to adhere/interact with any of the 
exoglycosidase pre-treated monolayers when compared to untreated monolayers (Fig 4. 
9A). Despite this, all three Pattern E GAS M-types formed biofilms with a significantly 
increased biomass on all three exoglycosidase (α1-6 mannosidase, α1-2,3 mannosidase, 
and Sialidase A) pre-treated monolayers compared to the untreated control (Fig 4.9B). 
Despite this, the number of colony forming units within the biofilms did not differ 

















































































































Figure 4.9. Pattern E GAS M-types M9, M44, and M90 assessed for their biofilm formation on 
exoglycosidase pre-treated Detroit 562 monolayers. (A) Initial adherence enumerated for planktonic 
GAS following 2 h incubation. 72 h biofilms were assessed for (B) biofilm biomass via crystal violet 
staining and (C) colony forming units via enumeration. Data represents mean ± SEM, with statistical 
analysis performed using a one-way ANOVA with Tukey’s multiple comparisons test ** (p ≤ 0.01) and 
*** (p ≤ 0.001); n = 3 biological replicates, with 3 technical replicates each. 
4.3.3.2. Biofilm EPS 
DMMB staining of EPS associated S-GAGs found no significant differences in EPS for 
M9 or M44 biofilms formed on any of the exoglycosidase (α1-6 mannosidase, α1-2,3 
mannosidase, and Sialidase A) pretreated monolayers when compared to untreated 
control (Fig 4.10A). However, M90, was found to increase in EPS S-GAG content for 
biofilm formed on α1-6 mannosidase pre-treated monolayers (Fig 4.10A). M90 EPS was 
further examined for eDNA and protein content via Sytox Blue and SYPRO ruby stains 




































































associated eDNA or protein in any of the M90 biofilms formed on exoglycosidase vs 
untreated monolayers. Interestingly, compared to other GAS M-types previously 
























































































Figure 4.10. M90 has significantly increased EPS (S-GAGs) when biofilms were formed on α1-6 
mannosidase pre-treated pharyngeal cell monolayers. M9, 44, and 90 biofilms were assessed for (A) 
EPS via DMMB staining of sulphated GAGs. (B) M90 biofilm EPS was further inspected for its EPS 
associated components (eDNA and protein) via fluorescent staining with Sytox™ Blue and FilmTracer™ 
SYPRO® Ruby biofilm matrix stain, respectively. Data represents mean ± SEM, with statistical analysis 
performed using a one-way ANOVA with Tukey’s multiple comparisons test *** (p ≤ 0.001); n = 3 




































































4.3.3.3. Visualisation of M90 GAS biofilms 
M90 EPS was found to increase significantly for biofilms formed on α1-6 mannosidase 
pre-treated monolayers. Hence, M90 GAS biofilm formation on each of the 
exoglycosidase pre-treated and untreated monolayers were further visually inspected via 
SEM imaging. Biofilms formed on both untreated and exoglycosidase pre-treated 
monolayers show M90 GAS cocci chains arranged into three dimensional aggregated 
structures with EPS matrix material present (Fig 4.11A, C, E, and G). M90 GAS biofilm 
formed on α1-6 mannosidase pre-treated pharyngeal monolayers (Fig 4.11C) appeared to 
produce more EPS matrix material associated with the aggregated GAS cocci when 
compared to GAS biofilm formed on the untreated control or the other exoglycosidase 
pre-treated monolayers. Two varieties of EPS were found, the web-like mesh matrix 
(small black arrows) and a more globular matrix (big black arrows) that both extend from 
the cocci cell surface of these biofilm cells. Untreated and exoglycosidase pre-treated 
Detroit 562 pharyngeal monolayers (without biofilms) were also imaged as controls to 
ensure that each exoglycosidase treatment did not affect pharyngeal cell 




















Figure 4.11. Visual inspection of 72 h M90 GAS biofilms captured via SEM reveals substantial EPS 
present in biofilms formed on exoglycosidase pre-treated pharyngeal cell monolayers. Images are 
representative of biofilms formed on (A) untreated, (C) α1-6 mannosidase, (E) α1-2,3 mannosidase, and 
(G) Sialidase A pre-treated pharyngeal monolayers. GAS biofilms show chained cocci (white arrows) 
arranged into three dimensional aggregated structures with EPS matrix material present (big and small 
black arrows). Biofilms were imaged using the JEOL JSM-7500 microscope at 15 000 x magnification. 
Respective Detroit 562 pharyngeal cell monolayer controls; (B) untreated, (D) α1-6 mannosidase, (F) α1-
2,3 mannosidase, and (H) Sialidase A pre-treated were also imaged at 500 x magnification. SEM images 





The most common sites of GAS infection are the epithelia of the skin and throat, resulting 
in superficial infections such as pharyngitis and impetigo respectively. However, GAS 
can also cause several more serious invasive infections (e.g. bacteremia, sepsis, and 
necrotising fasciitis) and numerous autoimmune sequelae (e.g. rheumatic heart disease 
and acute post-streptococcal glomerulonephritis) (Walker et al., 2014). Collectively, 
these disease etiologies are responsible for an alarming global health burden. The global 
burden of GAS disease is further compounded by the reported antibiotic treatment failure 
rate and a lack of vaccine (Walker et al., 2014). 
Within the last decade, the appreciation of the host glycome in mediating GAS adherence, 
colonisation, and its role in subsequent disease manifestation has gained interest. 
Previously, GAS M proteins of pattern A-C GAS M-types M1, 3, and 12 have been 
implicated in recognising ABO(H) histo-blood group antigens and Lewis structures found 
on HBE cells (De Oliveira et al., 2017, De Oliveira et al., 2019). However, this was in the 
context of planktonic GAS, and these studies only assessed three GAS serotypes – all 
belonging to the same emm pattern. Given the diversity of over 200+ circulating GAS 
emm types, and the growing appreciation of biofilm formation as an important GAS 
virulence mechanism (Baldassarri et al., 2006, Roberts et al., 2012, Marks et al., 2014, 
Walker et al., 2014, Vyas et al., 2019), there is an unmet need to increase our 
understanding of the interactions between GAS and host glycans. Specifically, 
assessment of GAS biofilm formation in response to pharyngeal cell surface glycans with 
a broad range of GAS strains representative of all emm patterns is warranted.  
Previous research presented in this thesis showed that the removal of mannose and sialic 
acid glycan residues from the surface of Detroit 562 pharyngeal cell monolayers 
significantly enhanced M12 GAS biofilm formation via EPS production. To explore the 




eight GAS isolates were studied using similar methodology. To build upon this, GAS M-
types were categorised by their emm patterns (pattern A-C, D, and E) to ascertain if there 
were any trends or correlation between GAS M-types belonging to distinct emm patterns 
and the biofilms formed in response to the de-glycosylated pharyngeal cell monolayers. 
Overall, the targeted removal of terminal mannose and sialic acid residues that 
predominate the surface of Detroit 562 pharyngeal cells resulted in increased biofilm 
biomass independent of initial adherence and biofilm CFU for all eight GAS M-types. 
This response was in a glycan- and strain-dependent manner and suggests that the 
influence the host glycome imparts on the GAS biofilm phenotype is not limited to a 
single strain or M-type. Biofilms of three M-types (M3, 98, and 90) which were all found 
to have increased EPS on α1-6 mannosidase pre-treated monolayers were further 
assessed, however, there were no differences in the eDNA and protein components 
between biofilms formed on untreated and exoglycosidase pre-treated monolayers. SEM 
imaging of biofilms formed on untreated and exoglycosidase pre-treated monolayers for 
all three M-types found GAS cocci chains arranged in aggregated three-dimensional 
structures. Two distinct varieties of EPS (web/thread-like and the globular form) were 
apparent, however, prevalence of each variety differed among the three M-types. In a 
study by Lembke et al. (2006), they described the thread-like EPS present only in M2 
GAS biofilms, whereas the M18 GAS biofilm was completely absent of the thread-like 
EPS structures. Hence, it is likely that this EPS material may be produced at varying 
capacities in a strain dependent manner underscoring the subtle differences and variability 
among GAS strains. Future studies should consider additional CLSM imaging of these 
biofilms and their EPS matrix given some of the limitations presented by SEM. 
Particularly, the dehydration that occurs during SEM sample prep which impacts the EPS 




especially given the otherwise highly hydrated nature of biofilms and their EPS (Williams 
and Bloebaum, 2010).  
Although this study revealed that EPS production may be a contributing factor to the 
increased GAS biofilm biomass among some M-types, a notable limitation of this study 
was the use of a single EPS staining method. DMMB staining is used extensively for 
staining S. aureus biofilms which are relatively well characterised. The main constituent 
of S. aureus biofilm EPS has been identified as a poly-b-1,6-linked N-acetylglucosamine 
rich intracellular polysaccharide adhesin (PIA). DMMB detects S-GAGs which are 
structurally similar to PIAs, and hence this staining method is thought to confidently and 
directly ascertain the amount of EPS present in S. aureus biofilms (Pantanella et al., 
2013). Unfortunately, GAS biofilm EPS remains poorly defined. Consequently, sole 
reliance on one EPS stain as a means to define total EPS may in fact underrepresent the 
amount of EPS detected among strains. Hence, future characterisation of GAS EPS 
should consider using a broader repertoire of stains/detection methods. For example, 
Concanavalin A coupled to a fluorophore which would enable the detection of a broader 
suite of polysaccharides, and may perhaps better capture total biofilm EPS (González-
Machado et al., 2018). 
In terms of categorising M-types by emm pattern to see if any trends or correlations were 
apparent, with the exception of pattern E GAS M-types (M9, 44, and 90), variances in 
biofilm formation in response to differentially exposed pharyngeal cell surface glycans 
were not emm pattern specific. As such, future studies should instead consider 
systematically exploring the various virulence factors that GAS possesses, and their role 
in mediating biofilm formation at the host-glycan interface. Firstly, the role of M protein 
and M family proteins (M-like and M-related protein) and their lectin like properties 
should be explored via knockouts of the M protein family genes; emm (encoding M 




aid in further defining the functions of each of these distinct proteins in glycan dependent 
GAS biofilm formation. In addition to exploring M family proteins, the role of serum 
opacity factor (SOF) which is unique to pattern E M-types should be assessed. In this 
study, only pattern E GAS M-types were found to exhibit a pattern specific response, with 
significantly increased biofilm biomass in response to all three exoglycosidase pre-treated 
monolayers. Hence pattern E M-types should be examined in the context of SOF, an 
important surface exposed molecule of GAS (Courtney and Pownall, 2010). Since its 
discovery in 1938, SOF has been found to have several important roles, including 
involvement in GAS adhesion and subsequent colonisation of the tissues of the throat and 
skin giving them MSCRAMM (microbial surface component recognising adhesive 
matrix molecule) like properties (Courtney et al., 2002, Oehmcke et al., 2004, Courtney 
and Pownall, 2010). Moreover, SOF has previously been found to bind various host 
glycoproteins (fibronectin, fibrinogen, and fibulin-1) which are all important in bacterial 
adhesion (Oehmcke et al., 2004). As such, it is possible that SOF has enacted on the 
glycoproteins present on the Detroit 562 pharyngeal monolayer, potentiating biofilm 
formation among the pattern E M-types assessed. However, to date, the role SOF plays 
in GAS biofilm formation has not been investigated. 
In addition to the above, other GAS virulence factors such as hyaluronic acid capsule 
should be investigated. Currently, the role of GAS capsule in biofilm formation remains 
to be thoroughly investigated, despite its importance as a virulence factor for GAS. It has 
been implicated as an important component in the adhesion and attachment of GAS to 
keratinocytes (Schrager et al., 1998). In terms of capsule involvement in biofilms, one 
study found that highly encapsulated GAS had a higher propensity to grow in an 
aggregated state (Cleary and Larkin, 1979). On the other hand, some studies have 
suggested that capsule impedes GAS adhesion/internalisation, with this inhibitory effect 




with the host (Kawabata et al., 1999). As such, each of these strains should be assessed 
for the degree to which they are encapsulated via quantification of hyaluronic acid capsule 
biomass assays (Maamary et al., 2010). Encapsulation may be differentially mediating 
and facilitating biofilm formation between strains at each of the exoglycosidase pre-
treated surfaces. This was particularly apparent for the M98 strain used in this study which 
is a covS mutant that is highly encapsulated (Maamary et al., 2010). It was the only pattern 
D GAS isolate exhibiting significant increases in biofilm biomass when grown on all 
three exoglycosidase pre-treated surfaces. Lastly, capsule is surface expressed, and 
composed of a polymer of glucuronic acid and N-acetylglucosamine (Stoolmiller and 
Dorfman, 1969), and perhaps there is some interplay between the interactions of these 
capsule-associated monosaccharides with those exposed on the pharyngeal cell surface 
upon exoglycosidase treatment. This is feasible given that GAS capsule can differentially 
bind to CD44, a transmembrane glycoprotein found on human keratinocytes, dependent 
on CD44 glycosylation profile (Skelton et al., 1998).  
Other biofilm specific virulence mechanisms that trigger and prompt biofilm formation 
should also be assessed. One prominent avenue to explore is quorum sensing (QS). This 
cell-to-cell communication mechanism utilises signalling molecules to coordinate gene 
expression in response to a variety of stimuli/pressures/environmental conditions 
(Jimenez and Federle, 2014). As per other Gram-positive bacteria, GAS genomes contain 
several QS systems that mediate genetic exchange, competence, virulence factor 
secretion, and enhance biofilm formation (Jimenez and Federle, 2014, Aggarwal et al., 
2015). Although some serotypes may possess only a subset of QS systems, regulator gene 
of glucosyltransferase 2/3 (Rgg2/3) QS system is ubiquitous among all GAS isolates 
(Gogos et al., 2018). One study by Chang et al. (2015) found that the Rgg2 coupled with 
neighbouring short hydrophobic peptide (SHP) genes (Rgg2-SHP QS system) are actively 




resulted in increased biofilm formation, which the authors suggested was necessary for 
successful colonisation and persistence within the host (Chang et al., 2015). This is 
plausible as transcriptomic studies have shown that gene expression needed for mannose 
uptake is triggered in GAS upon growth on various host soft tissues, saliva, and blood 
which are environments rich in mucins and glycoproteins containing mannose (Graham 
et al., 2005, Shelburne et al., 2005). Similarly, in the context of this work, liberation of 
terminal sialic acid or mannose upon exoglycosidase pre-treatment may reveal other 
mannose residues present on the glycoproteins that decorate the Detroit 562 pharyngeal 
cell surface. These in turn may be triggering this QS system resulting in increased biofilm 
biomass. Moreover, other non-glucose monosaccharides such as galactose which are 
present on glycans of the oropharynx (and on the Detroit 562 pharyngeal cells utilised in 
this study) have been noted to trigger QS systems among several streptococci (Gogos et 
al., 2018). Taken together, there is ample evidence to suggest that host glycans may 
directly impact GAS QS systems, which in turn shape and mediate GAS biofilm 
formation and should be the focus of further study.  
Overall, the eight GAS emm-types assessed displayed increases in biofilm biomass in a 
strain- and glycan- dependent manner. These findings underscore the importance of the 
host glycomic landscape in mediating GAS biofilm formation. Further study is needed 
into characterising the GAS biofilms that form on the host surface. Such studies could 
lead to the development of novel therapeutic drugs and strategies that negate or hamper 





Chapter 5: Conclusions and future directions 
GAS is a human specific pathogen, and colonisation and subsequent biofilm formation is 
inextricably facilitated by distinct interactions with the human host and tissue surface. 
However, little is known about the role of GAS biofilms in pathogenesis. Although the 
contributions of previous in vitro plate-based studies have been valuable, most of these 
studies failed to mimic the host environment, with many studies utilising abiotic surfaces 
(plastic, glass, silicone etc). The GAS-pharyngeal cell model developed and optimised in 
this study supports and cultivates GAS biofilms of a variety of GAS M-types. Although 
M1 and M12 utilised in this study are heavily associated with GAS pharyngitis, utilising 
a broader variety of clinical GAS isolates derived directly from GAS pharyngitis/throat 
infections is encouraged.  
The efficacious GAS-pharyngeal cell biofilm model developed herein supports long-term 
GAS biofilm formation, which more closely resemble those seen in vivo and is thus a far 
superior model. The development of this model has furthered, and will continue to, the 
field’s understanding of GAS biofilm formation.  
However, this model can be further built upon and optimised. Future studies should 
endeavor to better encapsulate the host environment. Specifically, the implementation of 
live epithelial substratum, as opposed to the fixed pharyngeal monolayers used here - as 
this is more physiologically relevant. There should also be consideration into the 
development of flow-based models with media supplemented with saliva given that the 
pharynx is a site of constant movement, with saliva flowing through the oropharynx 
(Sawair et al., 2009, Proctor et al., 2018). This is important because both flow/saliva can 
impact the physical/spatial structure (initial adherence and biofilm formation, 
arrangement, architecture) and the physiology and genetic expression of bacteria within 
these biofilms (Jin et al., 2004, Ahn et al., 2008, Inui et al., 2019). Thus, utilisation of a 




slides could be used to co-culture GAS biofilms atop pre-formed monolayers. On either 
side of the chamber slides there is inlet and outlet tubing which enables fresh media to 
flow through (e.g. THY supplemented with saliva) at distinct flow rates that mimic the 
salivary flow rate found at the pharynx.  
GAS is a human specific pathogen which readily colonises the epithelia of the pharynx 
and skin (Bessen et al., 1996). Whilst this process is complex, dynamic, and multifaceted, 
glycans which are abundantly present on all host epithelial surfaces have recently gained 
attention as an important component mediating GAS pathogenesis (De Oliveira et al., 
2017, De Oliveira et al., 2019). However, much remains to be understood of the glyco-
interactions occurring at the host-GAS interface, with much of the prior research having 
only been conducted in the context of planktonic GAS.  
The GAS-pharyngeal cell biofilm model developed here has further served to elucidate 
for the first time, the role of pharyngeal cell surface glycans in GAS biofilm formation 
among prominent GAS pharyngitis-associated M-types, as well as a diverse set of GAS 
M-types associated with a variety of GAS diseases. Removal of pharyngeal cell surface 
glycans increased biofilm biomass, independent of initial planktonic GAS adherence and 
the live cells of the biofilm determined upon culturing. With the findings indicating that 
EPS production was a likely contributor to the increased biofilm biomass, particularly for 
M12 GAS biofilms formed on pharyngeal monolayers removed of their terminal mannose 
and sialic acid residues.  
However, much remains unknown of the GAS EPS, requiring further investigation. In the 
current study, the presence of eDNA and protein in the EPS was confirmed using selective 
staining. S-GAG polysaccharides of the EPS were also stained, however, overall 
polysaccharide content of the EPS of biofilms formed on untreated and exoglycosidase 
pre-treated monolayers is necessary. EPS-associated polysaccharide content should be 




portion of a biofilms EPS (Flemming and Wingender, 2010, Karygianni et al., 2020). 
Assessment into EPS associated polysaccharide content can be done via staining with 
fluorescent stains such as concanavalin A conjugated to a fluorophore such as 
tetramethylrhodamine which will detect a broader variety of polysaccharides (González-
Machado et al., 2018). Moreover, it would be interesting to profile and identify the 
secreted glycans present in the EPS of these GAS biofilms, given that high molecular 
weight polysaccharides have been thought to act as an important scaffold to which other 
EPS components (eDNA, protein, lipids etc) attach and interact with (Sutherland, 2001). 
One study found that the secreted monosaccharide composition of biofilm EPS of 
ESKAPE pathogens (Enterococcus faecalis, S. aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, P. aeruginosa, and Enterobacter spp.) were found to differ 
between species (Bales et al., 2013). The study found high total mannose content across 
all tested strains, with P. aeruginosa and A. baumannii total EPS secreted polysaccharide 
content comprised of 80-90% mannose. E. coli was found to have the least mannose 
(10%), and K. pneumoniae and S. epidermidis strains contained 40-50% mannose. Other 
sugars were also detected, with galactose and glucose present in all strains (Bales et al., 
2013). Similarly, in the context of this thesis, the EPS secreted polysaccharide content of 
biofilms formed on untreated vs exoglycosidase pre-treated monolayers could be 
interrogated to survey for any commonalities and differences in polysaccharide content. 
This may reveal distinct abundances of monosaccharides being secreted into the EPS 
within each GAS M-type when grown on each of the exoglycosidase pre-treated surfaces. 
The mechanisms underpinning EPS production should also be evaluated to support our 
hypothesis that the witnessed biofilm biomass increases were indeed due to increased 
EPS production which was particularly evident in M12 GAS biofilms. This can be done 
by genomic sequencing of GAS strains to identify potential genes involved in EPS 




three gene clusters (PA1381-1393, PA2231-2240, and PA3552-3558) were linked to EPS 
production (Matsukawa and Greenberg, 2004). Mutants were constructed with 
chromosomal insertions at PA1383, PA2231, and PA3552. PA2231 mutant showed a 
severe defect in biofilm formation as a direct result of reduced EPS production 
(Matsukawa and Greenberg, 2004). Similarly, identified GAS EPS genes can be knocked 
out, and EPS/consequent biofilm formation determined on untreated vs exoglycosidase 
pre-treated monolayers. 
Finally, M12 GAS biofilms were assessed for penicillin tolerance. The GAS biofilms 
formed displayed significantly increased penicillin tolerance dependent on the host cell 
glycome. These findings describe the effect of host glycosylation on GAS biofilm 
formation, and GAS biofilm formation broadly as an important proponent in penicillin 
tolerance in vitro. Future studies should consider assessing the antibiotic tolerance 
profiles of these biofilms and the biofilms of the other M-types towards other antibiotics 
commonly prescribed for the treatment of GAS infection; ceftriaxone, cephalexin, 
clindamycin, erythromycin, and rifampin (Conley et al., 2003). 
To explore the impact of host glycan modification on GAS biofilm formation more 
broadly, an additional eight GAS isolates were studied using similar methodology. To 
build upon this, GAS M-types were categorised by their emm patterns (pattern A-C, D, 
and E) to ascertain if there were any trends or correlation between GAS M-types 
belonging to distinct emm patterns and the biofilms formed in response to the de-
glycosylated pharyngeal cell monolayers. Overall, the targeted removal of terminal 
mannose and sialic acid residues that predominate the surface of Detroit 562 pharyngeal 
cells resulted in increased biofilm biomass independent of initial adherence and biofilm 
CFU for all eight GAS M-types. This response was in a glycan- and strain-dependent 
manner and suggests that the influence the host glycome imparts on the GAS biofilm 




M-types, variances in biofilm formation in response to differentially exposed pharyngeal 
cell surface glycans were not emm pattern specific. Future studies should generally 
consider looking at knockouts of M protein (and other M family proteins; M-related and 
M-like protein) and other virulence factors (e.g. serum opacity factor) to determine the 
precise role of these major surface expressed proteins in GAS biofilm formation at the 
pharyngeal cell glycan interface. Moreover, given the implication of other several 
important GAS virulence factors (e.g. capsule, pili, SpeB etc) in mediating GAS biofilm 
formation, these should also be assessed to see how these may also shape and drive GAS 
biofilms forming at the pharyngeal glycan interface. 
In conclusion, an efficacious GAS-pharyngeal cell biofilm model that can support long-
term biofilm formation has been developed, with biofilms formed resembling those seen 
in vivo. The model has been used to investigate for the first time, GAS biofilm formation 
upon the alteration of the Detroit 562 pharyngeal cell surface glycome. Here, it has been 
shown that modulation of the pharyngeal glycome has a direct impact on GAS biofilm 
formation, with increases in EPS likely to play an important role. Given the increasingly 
appreciated importance of glycans in the host-pathogen relationship and the abundance 
of glycosylated structures in the oropharynx, this work contributes to an improved 
understanding of the role of host glycans in the pathogenesis of GAS pharyngitis and 
antibiotic treatment failure and may contribute towards the development of novel 
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Appendix A: Media and general buffer composition 
Unless stated otherwise, all media and buffers were made up to volume with distilled 
H2O 
Media composition 
Todd-Hewitt broth (THY)  
Todd-Hewitt   30 g/L  
Yeast extract   10 g/L  
THY agar (THYA)  
THY  
Agar    15g/L  
Dulbecco’s Modified Eagle Medium (DMEM) F12 
DMEM F12 powder  
NaHCO3    29 mM 
Supplemented with L-glutamine (2mM) and 10% (v/v) foetal bovine serum  
Buffer composition  
1 × Phosphate buffer saline (PBS)  
NaCl    8 g/L  
KCl    0.2 g/L  
Na2HPO4   1.44 g/L  
KH2PO4   0.24 g/L  





































































































Figure B. Graphs of planktonic overnight GAS cultures enumerated for their bacterial counts 
(CFU/mL). GAS M types have been categorized into Emm patterns; A-C (M1, M3, and M12), D 
(M53, M98, and M108), and E (M9, M44/61, and M90). Data represents mean ± SEM, with statistical 
analysis performed using a one-way ANOVA with Tukey’s multiple comparisons test, no significant 
differences noted among GAS M types belonging to their respective Emm pattern; n = 3 biological 




Appendix C: Proposed N-glycans structures identified on the Detroit 
562 pharyngeal cell surface 
Table C. Proposed N-glycan structures identified by PGC-LC-ESI-MS/MS following PNGase F 
treatment of membrane proteins extracted from Detroit-562 pharyngeal cells. Structures are assigned 
based on precursor m/z, retention time and MS2 fragmentation spectra (Ceroni et al., 2008, Harvey et al., 
2008, Everest-Dass et al., 2012, Everest-Dass et al., 2013). Relative abundances were calculated based on 
integration of peak area of extracted ion chromatograms and reported as mean ± SEM across three 
biological replicates. Abundances of structural isomers sharing the same m/z, monosaccharide composition 
and terminal monosaccharide presentation have been combined for clarity. Glycans are represented using 
conventional graphical nomenclature as per (Varki et al., 2015). Red triangle = fucose (dHex), yellow circle 
= galactose (GalNAc), blue square = N-acetylglucosamine (GlcNAc), green circle = mannose (Man), purple 









Appendix D: Confirming removal of N-linked glycan structures via 


































Figure D. Lectin binding assay confirming removal of N-linked glycans via PNGase F treatment of 
Detroit 562 pharyngeal cell monolayers. N-linked glycan removal was confirmed via Concanavalin A 
Alexa Fluor 647 lectin binding to untreated and PNGase F pre-treated pharyngeal cell monolayers. Bound 
Concanavalin A Alexa Fluor 647 was detected spectrofluorometrically at excitation 625-30 nm/emission 
680-30 nm. Data represents mean ± SEM, with statistical analysis performed, **** (P ≤ 0.0001); n = 3 




Appendix E: Confirming removal of mannose and sialic acid via 































































Figure E. Lectin binding assay confirming removal of terminal mannose and sialic acid residues via 
exoglycosidase treatment of Detroit 562 pharyngeal cell monolayers. Glycan removal was confirmed 
via lectin binding assay with α1-6 mannosidase and α1-2,3 mannosidase pre-treated pharyngeal cell 
monolayers incubated with biotinylated Hippeastrum Hybrid lectin (binding mannose residues), and 
Sialidase A pre-treated pharyngeal cell monolayers incubated with biotinylated Sambucus negra lectin 
(binding sialic acid residues). Untreated pharyngeal cell monolayer controls were incubated with respective 
lectins. Data represents mean ± SEM, with statistical analysis performed, ** (P ≤ 0.01) and *** (P ≤ 0.001); 




Appendix F: Minimum inhibitory concentration (MIC) Assay 









































































































Figure F. Minimum inhibitory concentration (MIC) determined for planktonic M12 GAS after 24 h 
challenge with penicillin. Data displays MIC graphs generated for 3 biological replicates (A-C). Data 
represents mean ± SEM; n = 3 biological replicates, with 3 technical replicates each. 
